Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	KMT2C KMT2A KMT2D	7.29e-05	8	222	3	GO:0140945
GeneOntologyMolecularFunction	molecular adaptor activity	UIMC1 TCERG1L PPRC1 BCORL1 MED14 PPP1R13L JMY AXIN2 DHX9 KMT2C KAT2B DLG1 MICAL3 TAPBP SPPL2C TCF4 AKAP5 SASH1 MED9 ATG2B TAB3 KMT2D BRD4 HGS EIF4G1 SMARCA4 HERPUD1 PBXIP1 HCFC1 PCM1 TP53BP1	1.05e-04	1356	222	31	GO:0060090
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	KMT2C KMT2A KMT2D	1.54e-04	10	222	3	GO:0140999
GeneOntologyMolecularFunction	transcription coregulator activity	TCERG1L PPRC1 BCORL1 MED14 PPP1R13L JMY DHX9 KMT2C KAT2B TCF4 MED9 KMT2D BRD4 SMARCA4 PBXIP1 HCFC1 TP53BP1	1.93e-04	562	222	17	GO:0003712
GeneOntologyBiologicalProcess	regulation of cell cycle	CYLD ANKRD31 UIMC1 JADE3 MECOM TSC22D2 CUL7 LILRB1 AXIN2 CDCA2 KAT2B BUB1 DLG1 NPPC CAMSAP3 PPP1R13B E4F1 TEX14 SIPA1 CREB3L1 MADD RFWD3 PBRM1 MAPK15 BRD4 EIF4G1 SMARCA4 TTI1 HCFC1 NEK11 TP53BP1	1.02e-05	1256	219	31	GO:0051726
GeneOntologyBiologicalProcess	negative regulation of cell cycle	UIMC1 TSC22D2 LILRB1 KAT2B BUB1 DLG1 NPPC CAMSAP3 PPP1R13B TEX14 SIPA1 CREB3L1 RFWD3 BRD4 TTI1 NEK11 TP53BP1	1.02e-05	464	219	17	GO:0045786
Domain	BROMODOMAIN_2	KAT2B KMT2A ATAD2 TRIM33 PBRM1 BRD4 SMARCA4	3.92e-07	41	215	7	PS50014
Domain	Bromodomain	KAT2B KMT2A ATAD2 TRIM33 PBRM1 BRD4 SMARCA4	4.66e-07	42	215	7	IPR001487
Domain	BROMO	KAT2B KMT2A ATAD2 TRIM33 PBRM1 BRD4 SMARCA4	4.66e-07	42	215	7	SM00297
Domain	-	KAT2B KMT2A ATAD2 TRIM33 PBRM1 BRD4 SMARCA4	4.66e-07	42	215	7	1.20.920.10
Domain	BROMODOMAIN_1	KAT2B ATAD2 TRIM33 PBRM1 BRD4 SMARCA4	3.75e-06	37	215	6	PS00633
Domain	Bromodomain	KAT2B ATAD2 TRIM33 PBRM1 BRD4 SMARCA4	4.40e-06	38	215	6	PF00439
Domain	FYrich_C	KMT2C KMT2A KMT2D	1.48e-05	5	215	3	IPR003889
Domain	FYrich_N	KMT2C KMT2A KMT2D	1.48e-05	5	215	3	IPR003888
Domain	FYRC	KMT2C KMT2A KMT2D	1.48e-05	5	215	3	SM00542
Domain	FYRN	KMT2C KMT2A KMT2D	1.48e-05	5	215	3	SM00541
Domain	FYRN	KMT2C KMT2A KMT2D	1.48e-05	5	215	3	PF05964
Domain	FYRC	KMT2C KMT2A KMT2D	1.48e-05	5	215	3	PF05965
Domain	FYRC	KMT2C KMT2A KMT2D	1.48e-05	5	215	3	PS51543
Domain	FYRN	KMT2C KMT2A KMT2D	1.48e-05	5	215	3	PS51542
Domain	EPHD	JADE3 KMT2C KMT2A KMT2D	1.06e-04	22	215	4	PS51805
Domain	VHS	STAM HGS GGA1	1.20e-04	9	215	3	PS50179
Domain	VHS	STAM HGS GGA1	1.20e-04	9	215	3	PF00790
Domain	VHS	STAM HGS GGA1	1.20e-04	9	215	3	SM00288
Domain	VHS_dom	STAM HGS GGA1	1.20e-04	9	215	3	IPR002014
Domain	Bromodomain_CS	KAT2B PBRM1 BRD4 SMARCA4	2.09e-04	26	215	4	IPR018359
Domain	SET_dom	KMT2C PRDM10 KMT2A KMT2D PRDM15	2.68e-04	50	215	5	IPR001214
Domain	SET	KMT2C PRDM10 KMT2A KMT2D PRDM15	2.68e-04	50	215	5	PS50280
Domain	ENTH_VHS	STAM HGS TTI1 GGA1	3.24e-04	29	215	4	IPR008942
Domain	Relaxin	RLN1 RLN2	3.93e-04	3	215	2	IPR022421
Domain	Post-SET_dom	KMT2C KMT2A KMT2D	7.54e-04	16	215	3	IPR003616
Domain	PostSET	KMT2C KMT2A KMT2D	7.54e-04	16	215	3	SM00508
Domain	POST_SET	KMT2C KMT2A KMT2D	7.54e-04	16	215	3	PS50868
Pathway	WP_MITOCHONDRIAL_GENE_EXPRESSION	PPRC1 NRF1 MTERF3 HCFC1	4.55e-05	19	153	4	M39544
Pathway	WP_MITOCHONDRIAL_GENE_EXPRESSION	PPRC1 NRF1 MTERF3 HCFC1	4.55e-05	19	153	4	MM15973
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	KMT2C KAT2B KMT2A KMT2D HCFC1	8.68e-05	42	153	5	M48018
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	UIMC1 CAAP1 JADE3 MED14 RREB1 DHX9 PHC3 PPIG PAPOLA MAGED2 SEC16A KMT2A DLG1 AFDN MICAL3 ZEB1 ARID4A CAMSAP3 FNBP4 AAK1 LARP1 ATAD2 SART1 KMT2D BRD4 EIF4G1 RBM6 SMARCA4 ACIN1 SNAI1 ZMYM4 PCM1 TP53BP1	1.43e-17	774	227	33	15302935
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	MAZ BCORL1 MECOM RREB1 DHX9 HOXA2 CDCA2 KMT2C PHC3 SYNJ1 MAGED2 SEC16A BAHCC1 ZEB1 LARP1 TRIM33 KMT2D PBRM1 ZFHX4 BRD4 SMARCA4 RAI2	2.71e-14	398	227	22	35016035
Pubmed	Human transcription factor protein interaction networks.	CYLD UIMC1 SLK MAZ BCORL1 MECOM CUL7 RREB1 ANKHD1 MYO5C CDCA2 KMT2C PHC3 KAT2B SINHCAF MAGED2 SEC16A KMT2A TCF4 ZEB1 ARID4A LARP1 PPP1R13B SOX13 TAB3 TRIM33 KMT2D PBRM1 ZFHX4 HGS EIF4G1 RBM6 SMARCA4 HCFC1 ZMYM4 PCM1 RBM34 RAI2 TP53BP1	3.45e-14	1429	227	39	35140242
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MAZ MCAM KPNA6 ZNF362 CUL7 PPP1R13L SNX19 CDCA2 SBF1 ARL13B SEC16A DLG1 MICAL3 C19orf25 KPNA2 RELCH ACOT8 AKAP5 CEP290 CAMSAP3 LMTK2 KIAA1549 PPP1R13B TNS2 STAM TAB3 MADD KMT2D PRPF3 HGS TTI1 DUSP10	4.79e-13	1049	227	32	27880917
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SLK MED14 ANKHD1 KMT2C SYNJ1 SEC16A KMT2A DLG1 AFDN KPNA2 ATG2B FNBP4 LARP1 PPP1R13B TAB3 KMT2D BRD4 SMARCA4 ACIN1 HCFC1 ZMYM4 PCM1 TP53BP1	2.19e-12	549	227	23	38280479
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	UIMC1 CAAP1 MAZ BCORL1 ZNF362 RREB1 DHX9 CDCA2 PHC3 SEC16A KMT2A AFDN CENPT ARID4A FNBP4 LARP1 SART1 TRIM33 PRPF3 BRD4 EIF4G1 RBM6 SMARCA4 ACIN1 HCFC1 ZMYM4 PCM1 TP53BP1	3.81e-11	954	227	28	36373674
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CYLD UIMC1 SLK JADE3 BCORL1 MED14 MECOM ZNF362 CDCA2 KAT2B SEC16A KMT2A MICAL3 CENPT ARID4A MED9 CEP290 ATG2B ATAD2 PBRM1 MED25 PRDM15 PCM1	5.54e-11	645	227	23	25281560
Pubmed	Interaction network of human early embryonic transcription factors.	BCORL1 MECOM RREB1 KMT2C KAT2B SEC16A KMT2A BAHCC1 ZEB1 ARID4A SOX13 TRIM33 KMT2D PBRM1 ZFHX4 SMARCA4 ZMYM4	2.00e-10	351	227	17	38297188
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	UIMC1 JADE3 MAZ BCORL1 MECOM RREB1 DHX9 CDCA2 KMT2C PHC3 PPIG SINHCAF KMT2A NKTR TAPBP KPNA2 ARID4A MED9 CEP290 FNBP4 E4F1 RFWD3 SART1 KMT2D PBRM1 PRPF3 BRD4 SMARCA4 ACIN1 HCFC1 ZMYM4	4.78e-10	1294	227	31	30804502
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	UIMC1 JADE3 MAZ BCORL1 ZNF362 RREB1 CDCA2 PHC3 KMT2A KPNA2 CENPT ARID4A ATAD2 PBRM1 CSN2 BRD4 SMARCA4 PRDM15 HCFC1 ZMYM4 RBM34	7.02e-10	608	227	21	36089195
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	MED14 KPNA6 DHX9 CDCA2 SBF1 MAGED2 UBR5 SEC16A NKTR KPNA2 FNBP4 LMTK2 LARP1 PBRM1 PRPF3 RBM6 SMARCA4 TP53BP1	8.70e-10	440	227	18	34244565
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	BCORL1 MECOM RREB1 ANKHD1 PHC3 SYNJ1 UBR5 BUB1 SEC16A ZEB1 ATG2B CAMSAP3 KMT2D ZFHX4 BRD4 ZMYM4 PCM1	2.84e-09	418	227	17	34709266
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	UIMC1 MCAM ZNF280B PPP1R13L MAGED2 SEC16A MAMLD1 AAK1 LARP1 STAM SART1 TRIM33 PRPF3 EIF4G1 HCFC1 ZMYM4 AHNAK2	6.95e-09	444	227	17	34795231
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CYLD UIMC1 BCORL1 MECOM KPNA6 CUL7 SYNJ1 UBR5 BUB1 SEC16A PPP1R13B SOX13 TRIM33 ZC3H7A MED25 RBM6 ZMYM4 PCM1 TP53BP1	1.37e-08	588	227	19	38580884
Pubmed	Functional proteomics mapping of a human signaling pathway.	UIMC1 MCAM PPP1R13L PAPOLA UBR5 AFDN TMEM139 SASH1 FNBP4 PPP1R13B E4F1 STAM SOX13 KMT2D PBRM1 BRD4 EIF4G1 CCDC181 GGA1	1.49e-08	591	227	19	15231748
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	SLK ANKHD1 MAGED2 SEC16A MICAL3 AAK1 LARP1 SIPA1 SART1 PRPF3 EIF4G1 ACIN1 PBXIP1 TP53BP1 AHNAK2	1.81e-08	360	227	15	33111431
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PPRC1 MED14 KDM6B ZNF236 ANKHD1 C2CD2L KMT2C SBF1 SYNJ1 SEC16A MICAL3 WNK2 BAHCC1 ZNF628 NRF1 SZT2 LMTK2 LARS2 MADD KMT2D BRD4 EIF4G1 TNK2 GGA1 HCFC1 AHNAK2	1.95e-08	1105	227	26	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CYLD CAAP1 MAZ MECOM KPNA6 ZNF362 CUL7 RREB1 ANKHD1 C2CD2L KAT2B UBR5 PCDH19 SEC16A BAHCC1 ACOT8 KIAA1549 SIPA1 SART1 TRIM33 PBRM1 ZFHX4 PRPF3 BRD4 SMARCA4 PCM1	2.37e-08	1116	227	26	31753913
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	DHX9 KAT2B KMT2A ATAD2 TRIM33 PBRM1 BRD4 SMARCA4	3.37e-08	75	227	8	25593309
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	UIMC1 CAAP1 MAZ MED14 ANKHD1 C2CD2L KMT2C PHC3 SBF1 TMEM266 KMT2A DLG1 AFDN TAPBP ACOT8 TBC1D30 CAMSAP3 AAK1 E4F1 ATAD2 CEP164 TRIM33 ZC3H7A PBRM1 EIF4G1 MED25 RBM6 PALM3 PBXIP1 ZMYM4	5.27e-08	1497	227	30	31527615
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	MECOM KPNA6 CUL7 ANKHD1 PRDM10 UBR5 KPNA2 TCF4 NRF1 ARID4A LARP1 E4F1 SART1 TRIM33 KMT2D ZFHX4 EIF4G1 SMARCA4 PRDM15 HCFC1 ZMYM4 TP53BP1	5.78e-08	857	227	22	25609649
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SECISBP2L SLK ANKHD1 SBF1 BUB1 KMT2A DLG1 AFDN C4A MICAL3 C4B TMEM223 RALGDS CAMSAP3 LARP1 MADD RFWD3 PBXIP1 HCFC1	6.64e-08	650	227	19	38777146
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CUL7 ANKHD1 SBF1 UBR5 SEC16A KMT2A AFDN LARP1 ATAD2 SART1 PBRM1 EIF4G1 RBM6 SMARCA4 ACIN1 HCFC1 PCM1 RBM34 TP53BP1	7.13e-08	653	227	19	22586326
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	JADE3 KDM6B ANKHD1 KMT2C SBF1 WNK2 RALGDS RELCH SASH1 SZT2 FNBP4 AAK1 LMTK2 KIAA1549 LARP1 TRIM33 ZMYM4	8.81e-08	529	227	17	14621295
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CYLD SLK DDN SBF1 SYNJ1 MAGED2 UBR5 SEC16A DLG1 AFDN WNK2 ZEB1 DSCAM CAMSAP3 AAK1 SIPA1 SART1 PBRM1 EIF4G1 SMARCA4 DGKI PCM1 TP53BP1	1.04e-07	963	227	23	28671696
Pubmed	A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency.	RTF1 KMT2C KMT2A KPNA2 PBRM1 SMARCA4 HCFC1	1.49e-07	61	227	7	20305087
Pubmed	A human MAP kinase interactome.	KPNA6 CCDC88B KMT2C C4A NKTR WNK2 RALGDS CEP290 PPP1R13B MADD ZC3H7A CSN2 HGS TNK2 DUSP10 HERPUD1	1.54e-07	486	227	16	20936779
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	MED14 KMT2C CAMSAP3 TRIM33 KMT2D PBRM1 MED25 SMARCA4 HCFC1 ZMYM4	1.66e-07	167	227	10	20362541
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	MED14 ZNF362 CDCA2 KMT2A SART1 TRIM33 KMT2D PBRM1 PRPF3 BRD4 SMARCA4 HCFC1	2.30e-07	268	227	12	33640491
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	PPP1R13L SEC16A AFDN KPNA2 TROAP CAMSAP3 AAK1 LARP1 STAM PBRM1 EIF4G1 RBM6 ACIN1 HCFC1 PCM1 TP53BP1	2.45e-07	503	227	16	16964243
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	CUL7 PPP1R13L DHX9 SBF1 MAGED2 UBR5 BUB1 SEC16A KMT2A ZFAND3 DSG1 CEP290 LARP1 SART1 PBRM1 PRPF3 ZNF804B PCM1	2.56e-07	639	227	18	23443559
Pubmed	Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.	KMT2C KMT2A KMT2D	2.74e-07	3	227	3	23932714
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	MED14 RTF1 PHC3 KMT2A KMT2D PBRM1 HCFC1	3.52e-07	69	227	7	28481362
Pubmed	Impact of WIN site inhibitor on the WDR5 interactome.	KMT2C SBF1 UBR5 KMT2A KMT2D HCFC1	3.61e-07	43	227	6	33472061
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	KMT2A TRAPPC8 PBRM1 ZFHX4 BRD4 SMARCA4 ACIN1 ZMYM4	4.06e-07	103	227	8	32744500
Pubmed	Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.	KMT2C KMT2A KMT2D HCFC1	8.40e-07	12	227	4	27563068
Pubmed	Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.	KMT2C UBR5 KMT2A KPNA2 KMT2D HCFC1	9.05e-07	50	227	6	37974198
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	KMT2C PPIG KMT2A KPNA2 SART1 KMT2D PRPF3 SMARCA4 ACIN1 HCFC1 TP53BP1	9.12e-07	251	227	11	31076518
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CYLD JADE3 KATNB1 PPIG SYNJ1 UBR5 AFDN MICAL3 CCHCR1 TROAP CEP290 CAMSAP3 AAK1 PPP1R13B CEP164 TAB3 ZC3H7A HGS GGA1 PCM1	9.76e-07	853	227	20	28718761
Pubmed	A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.	KMT2C KMT2A KMT2D	1.09e-06	4	227	3	23129768
Pubmed	The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers.	KMT2C KMT2A KMT2D	1.09e-06	4	227	3	24081332
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	SLK MCAM CDCA2 SEC16A DLG1 ATG2B LARP1 EIF4G1 HCFC1 PCM1 AHNAK2	1.11e-06	256	227	11	33397691
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	KPNA6 DHX9 KAT2B MAGED2 UBR5 KPNA2 DSG1 SART1 PRPF3 BRD4 SMARCA4 TTI1 HCFC1	2.02e-06	390	227	13	17643375
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	UIMC1 RREB1 KPNA2 SART1 PBRM1 EIF4G1 SMARCA4 ACIN1 TTI1 HCFC1 TP53BP1 AHNAK2	2.19e-06	332	227	12	32786267
Pubmed	K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.	CYLD UIMC1 RTF1 UBR5 BUB1 RELCH MED9 CAVIN3 STAM TAB3 MADD RFWD3 SART1 KMT2D HGS GGA1	2.67e-06	604	227	16	38803224
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	MECOM KPNA6 DHX9 KMT2A KPNA2 DSG1 FNBP4 LARP1 SART1 PBRM1 ZFHX4 PRPF3 EIF4G1 SMARCA4 ACIN1 RBM34	2.72e-06	605	227	16	28977666
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	CAAP1 ZNF362 DHX9 RTF1 PAPOLA SART1 PRPF3 BRD4 SMARCA4 ACIN1 HCFC1	2.92e-06	283	227	11	30585729
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	MAZ KMT2C KMT2A KPNA2 CEP290 TRIM33 KMT2D PBRM1 BRD4 SMARCA4 ACIN1 HCFC1 ZMYM4 TP53BP1	2.93e-06	469	227	14	27634302
Pubmed	Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells.	SLK DHX9 LARP1 SART1 PRPF3 EIF4G1 ACIN1 HCFC1	3.53e-06	137	227	8	37039823
Pubmed	The protein interaction landscape of the human CMGC kinase group.	MAZ MED14 CUL7 AXIN2 DHX9 RTF1 PPIG MAGED2 KPNA2 DSG1 TROAP MED9 LARP1 SART1 MAPK15 ACIN1 RBM34	3.75e-06	695	227	17	23602568
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	UIMC1 SLK ANKHD1 PHC3 PAPOLA SYNJ1 SEC16A KMT2A DSG1 ATG2B AAK1 LARP1 STAM PRPF3 SMARCA4 ACIN1 HCFC1 PCM1 TP53BP1 AHNAK2	3.84e-06	934	227	20	33916271
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SECISBP2L CAAP1 MAZ ANKHD1 PHC3 PPIG MAGED2 SEC16A KMT2A C4B NKTR PIPSL UQCRFS1P1 ACOT8 DSG1 FNBP4 AAK1 LARP1 PBRM1 EIF4G1 SMARCA4 ACIN1 HCFC1 PCM1 RBM34	3.99e-06	1371	227	25	36244648
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CYLD PPRC1 KPNA6 KDM6B DSCAML1 SYNJ1 ARL13B DLG1 AFDN DSCAM CEP290 STAM SEC31B BATF2 TXNDC11 MADD TRIM33 HECTD2 EIF4G1 SMARCA4 PBXIP1 ZMYM4 PCM1 PINK1	4.21e-06	1285	227	24	35914814
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CYLD MAZ CDCA2 SBF1 SYNJ1 SEC16A KMT2A AFDN SASH1 CAMSAP3 AAK1 LMTK2 LARP1 TAB3 MADD BRD4 EIF4G1 PCM1 AHNAK2	4.41e-06	861	227	19	36931259
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	MCAM SBF1 PCDH19 ARL13B SEC16A DLG1 MICAL3 AKAP5 SASH1 PPP1R13B STAM HGS OCLN	4.63e-06	421	227	13	36976175
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	UIMC1 CAAP1 GGT6 KPNA6 RREB1 KMT2C PHC3 SYNJ1 BUB1 TMEM266 C19orf25 TCF4 ZFAND3 NRF1 NR1H3 LCN2 ATAD2 BATF2 MAPK15 IRAK3 DUSP10 GGA1 PCM1 TP53BP1	4.68e-06	1293	227	24	15342556
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	SECISBP2L UIMC1 KPNA6 MYO5C CDCA2 DLG1 KPNA2 CAMSAP3 LMTK2 LARP1 ACIN1 RBM34	5.16e-06	361	227	12	30344098
Pubmed	Tissue-specific regulation of mouse core 2 beta-1,6-N-acetylglucosaminyltransferase.	RLN1 RLN2 CD5	5.41e-06	6	227	3	9341170
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	BCORL1 KPNA6 CUL7 RREB1 KMT2C PHC3 SINHCAF KMT2A TROAP FBXL17 KMT2D EIF4G1 HCFC1 ZMYM4	5.44e-06	495	227	14	27705803
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	GC KPNA6 RTF1 KMT2C KMT2A C4A MICAL3 C4B TAPBP CAMSAP3 FNBP4 SART1 HCFC1 RBM34	5.69e-06	497	227	14	36774506
Pubmed	The CP110-interacting proteins Talpid3 and Cep290 play overlapping and distinct roles in cilia assembly.	ARL13B CEP290 CEP164 PCM1	6.34e-06	19	227	4	24421332
Pubmed	Oncogenic ZMYND11-MBTD1 fusion protein anchors the NuA4/TIP60 histone acetyltransferase complex to the coding region of active genes.	PPIG KMT2A PBRM1 SMARCA4 ACIN1	7.92e-06	42	227	5	35705031
Pubmed	Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.	PHC3 SINHCAF KMT2A BAHCC1 ARID4A E4F1 PRPF3	8.28e-06	110	227	7	26841866
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SLK JMY DHX9 SBF1 SYNJ1 AJM1 SEC16A KMT2A DLG1 AFDN C4A MICAL3 C4B WNK2 UQCRFS1P1 CAMSAP3 AAK1 KIAA1549 LARP1 SIPA1 MADD EIF4G1 SMARCA4 PBXIP1 PCM1	8.33e-06	1431	227	25	37142655
Pubmed	Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome.	TSC22D2 LARP1 ATAD2 SART1 EIF4G1	8.91e-06	43	227	5	34672947
Pubmed	A census of human transcription factors: function, expression and evolution.	MAZ TSC22D2 RREB1 ZNF236 HOXA2 KMT2A TCF4 ZEB1 CENPT KIAA1549 NR1H3 E4F1 BATF2 SOX13 DMBX1 CREB3L1 KMT2D ZFHX4 SNAI1	9.34e-06	908	227	19	19274049
Pubmed	The relaxin gene is located on chromosome 19 in the mouse.	RLN1 RLN2 CD5	9.42e-06	7	227	3	1959604
Pubmed	Clustered PHD domains in KMT2/MLL proteins are attracted by H3K4me3 and H3 acetylation-rich active promoters and enhancers.	KMT2C KMT2A KMT2D	9.42e-06	7	227	3	36598580
Pubmed	Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition.	KDM6B KMT2C KMT2A KMT2D	9.69e-06	21	227	4	27626377
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	KMT2C KMT2A KMT2D HCFC1	1.18e-05	22	227	4	26886794
Pubmed	A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.	KPNA6 ANKHD1 DHX9 PAPOLA SEC16A KPNA2 TAB3 SMARCA4	1.21e-05	162	227	8	14743216
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	JADE3 MED14 ZNF362 JMY PHC3 KMT2A CENPT MED9 ATAD2 PBRM1 BRD4 MED25 SMARCA4 ACIN1	1.25e-05	533	227	14	30554943
Pubmed	The N-terminal domain of the Schaaf-Yang syndrome protein MAGEL2 likely has a role in RNA metabolism.	SLK DHX9 LARP1 EIF4G1 PCM1	1.25e-05	46	227	5	34265304
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	UIMC1 SLK ANKHD1 AFDN ATG2B ATAD2 PBRM1 EIF4G1 SNAI1	1.31e-05	215	227	9	35973513
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	BCORL1 ZNF362 DSCAML1 KMT2C SBF1 SYNJ1 NKTR CLEC19A CLBA1 MTERF3 CEP290 MADD TRIM33 DGKI PRDM15 RBM34	1.38e-05	689	227	16	36543142
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	MED14 KMT2C UBR5 KMT2A KMT2D HCFC1 TP53BP1	1.39e-05	119	227	7	23508102
Pubmed	A Conserved Role for Girdin in Basal Body Positioning and Ciliogenesis.	ARL13B CEP290 CEP164	1.50e-05	8	227	3	27623382
Pubmed	The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.	KMT2C KMT2A KMT2D	1.50e-05	8	227	3	22266653
Pubmed	Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation.	KMT2C KAT2B KMT2D	1.50e-05	8	227	3	21447625
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	KMT2C KMT2A KMT2D	1.50e-05	8	227	3	23130995
Pubmed	Quantitative Proteomics of the SMAD (Suppressor of Mothers against Decapentaplegic) Transcription Factor Family Identifies Importin 5 as a Bone Morphogenic Protein Receptor SMAD-specific Importin.	MED14 KMT2C MED9 MED25 HCFC1	1.54e-05	48	227	5	27703004
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	DHX9 KMT2C TRIM33 KMT2D PBRM1 PRPF3 ACIN1 HCFC1 ZMYM4	1.57e-05	220	227	9	35785414
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	CYLD MCAM DHX9 CDCA2 MAGED2 UBR5 ARL13B SEC16A DLG1 AFDN DSCAM SART1 TRIM33 CD5 OCLN GGA1 PCM1	1.59e-05	777	227	17	35844135
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CYLD SLK PPRC1 DDN SNX19 C2CD2L UBR5 PCDH19 SEC16A MICAL3 MADD ACIN1	1.71e-05	407	227	12	12693553
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	SECISBP2L RREB1 PPP1R13L DHX9 MAGED2 BUB1 SEC16A AFDN NKTR CCHCR1 RELCH NRF1 CEP290 ATG2B CAMSAP3 AAK1 LARP1 LCN2 SART1 PRPF3 TTI1 GGA1 TP53BP1	2.06e-05	1321	227	23	27173435
Pubmed	Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.	KMT2C KMT2A KMT2D	2.24e-05	9	227	3	22665483
Pubmed	The functional interactome landscape of the human histone deacetylase family.	KPNA6 RREB1 SINHCAF UBR5 SEC16A ARID4A ATG2B ATAD2 ACIN1 RBM34	2.26e-05	289	227	10	23752268
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	SLK CUL7 DSCAML1 BAHCC1 FNBP4 KIAA1549 MADD	2.46e-05	130	227	7	12421765
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	SLK MCAM C2CD2L UBR5 SEC16A ARID4A ATG2B LARP1 TRAPPC8 EIF4G1 PBXIP1 HCFC1 PCM1 AHNAK2	2.52e-05	568	227	14	37774976
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	ANKHD1 DHX9 CDCA2 UBR5 KPNA2 DSG1 SART1 TRIM33 PRPF3 HCFC1 ZMYM4	2.57e-05	357	227	11	37059091
Pubmed	An expanded Oct4 interaction network: implications for stem cell biology, development, and disease.	DHX9 KPNA2 TRIM33 SMARCA4 ACIN1 HCFC1	3.04e-05	91	227	6	20362542
Pubmed	LINC00152 Promotes Tumor Progression and Predicts Poor Prognosis by Stabilizing BCL6 From Degradation in the Epithelial Ovarian Cancer.	DHX9 DSG1 EIF4G1	3.18e-05	10	227	3	33282727
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	MAZ ZNF362 RREB1 DHX9 SINHCAF KPNA2 ARID4A LARP1 ZFHX4 HGS SMARCA4 ACIN1 HCFC1 TP53BP1	3.34e-05	583	227	14	29844126
Pubmed	Stabilization of the methyl-CpG binding protein ZBTB38 by the deubiquitinase USP9X limits the occurrence and toxicity of oxidative stress in human cells.	PPIG MAGED2 UBR5 SEC16A SART1 HCFC1	3.88e-05	95	227	6	29490077
Pubmed	Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.	C4A C4B	4.24e-05	2	227	2	22737222
Pubmed	Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.	C4A C4B	4.24e-05	2	227	2	16565498
Pubmed	Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.	C4A C4B	4.24e-05	2	227	2	15998580
Pubmed	Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating its activity and subcellular localization.	SIPA1 BRD4	4.24e-05	2	227	2	15456879
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	4.24e-05	2	227	2	19062096
Pubmed	Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.	C4A C4B	4.24e-05	2	227	2	19933335
Interaction	EGR2 interactions	BCORL1 MECOM RREB1 KMT2C KAT2B SEC16A KMT2A BAHCC1 TRIM33 KMT2D ZFHX4 SNAI1 HCFC1 ZMYM4	6.79e-09	171	222	14	int:EGR2
Interaction	RCOR1 interactions	BCORL1 MECOM RREB1 ANKHD1 SYNJ1 UBR5 BUB1 SEC16A KPNA2 CCHCR1 TCF4 ARID4A ATG2B CAMSAP3 KMT2D ZFHX4 BRD4 SMARCA4 SNAI1 ZMYM4 PCM1 TP53BP1	3.14e-08	494	222	22	int:RCOR1
Interaction	WWTR1 interactions	SLK ANKHD1 SYNJ1 SEC16A KMT2A DLG1 AFDN KPNA2 ZEB1 ATG2B LARP1 PPP1R13B TAB3 KMT2D BRD4 SMARCA4 HCFC1 PCM1 TP53BP1	2.42e-07	422	222	19	int:WWTR1
Interaction	SOX7 interactions	BCORL1 RREB1 KMT2C BAHCC1 TRIM33 KMT2D PBRM1 ZFHX4 SMARCA4	2.96e-07	82	222	9	int:SOX7
Interaction	H2BC8 interactions	UIMC1 JADE3 MAZ BCORL1 ZNF362 RREB1 RTF1 CDCA2 PHC3 PAPOLA SEC16A KMT2A ZEB1 CENPT ARID4A ATAD2 PBRM1 BRD4 SMARCA4 PRDM15 ZMYM4 RBM34	4.47e-07	576	222	22	int:H2BC8
Interaction	NUP43 interactions	JADE3 CUL7 RTF1 CDCA2 PHC3 UBR5 KMT2A NKTR CENPT DSCAM DSG1 SZT2 ARID4A LARP1 ATAD2 KMT2D PBRM1 EIF4G1 SMARCA4 ACIN1 HCFC1 ZMYM4 AHNAK2	4.62e-07	625	222	23	int:NUP43
Interaction	CBX3 interactions	UIMC1 JADE3 BCORL1 MECOM KPNA6 ZNF362 CUL7 RREB1 KDM6B RTF1 CDCA2 PRDM10 KMT2A ADAMTSL4 ZEB1 CENPT ATAD2 TRIM33 PRPF3 BRD4 SMARCA4 ZMYM4 TP53BP1	8.17e-07	646	222	23	int:CBX3
Interaction	H2BC21 interactions	UIMC1 JADE3 BCORL1 CUL7 RREB1 KDM6B C2CD2L RTF1 KAT2B SINHCAF KMT2A BAHCC1 DSG1 ARID4A MED9 FNBP4 ATAD2 PBRM1 BRD4 MED25 SMARCA4 HCFC1 ZMYM4 PINK1	8.19e-07	696	222	24	int:H2BC21
Interaction	CRX interactions	BCORL1 MECOM RREB1 KMT2C BAHCC1 C19orf25 SZT2 TNS2 TRIM33 KMT2D PBRM1 ZFHX4 HGS ZMYM4	9.29e-07	254	222	14	int:CRX
Interaction	ZFPL1 interactions	C2CD2L ARL13B SEC16A DLG1 TMEM139 AKAP5 MTERF3 LMTK2 KIAA1549 PPP1R13B STAM LCN2 CREB3L1 HGS OCLN PBXIP1 FRMD3 AHNAK2	2.58e-06	448	222	18	int:ZFPL1
Interaction	KLF8 interactions	MAZ BCORL1 MECOM RREB1 CDCA2 KAT2B SEC16A ZEB1 LARP1 TRIM33 KMT2D PBRM1 EIF4G1 ZMYM4 RBM34	4.00e-06	329	222	15	int:KLF8
Interaction	PIP4K2A interactions	PPRC1 RTF1 PPIG SBF1 LARP1 MADD RFWD3 CD6 PRPF3 BRD4 ACIN1 TP53BP1	5.21e-06	216	222	12	int:PIP4K2A
Interaction	GSC interactions	BCORL1 MECOM RREB1 KMT2C BAHCC1 SOX13 KMT2D ZFHX4	5.29e-06	87	222	8	int:GSC
Interaction	SMC5 interactions	UIMC1 CAAP1 MAZ BCORL1 ZNF362 RREB1 DHX9 CDCA2 PHC3 SEC16A KMT2A AFDN CENPT ARID4A FNBP4 LARP1 SART1 TRIM33 PRPF3 BRD4 EIF4G1 RBM6 SMARCA4 ACIN1 HCFC1 ZMYM4 PCM1 TP53BP1	5.61e-06	1000	222	28	int:SMC5
Interaction	BAG2 interactions	CYLD SLK BCORL1 MECOM CUL7 RREB1 PPP1R13L ANKHD1 RTF1 PHC3 PAPOLA BUB1 FNBP4 AAK1 PPP1R13B STAM TRIM33 BRD4 HGS SNAI1 PINK1	5.74e-06	622	222	21	int:BAG2
Interaction	MED25 interactions	MED14 SERTAD3 MED9 BRD4 HGS MED25 HCFC1 TP53BP1	8.71e-06	93	222	8	int:MED25
Interaction	H3C3 interactions	UIMC1 JADE3 BCORL1 ZNF362 RREB1 CDCA2 PHC3 KMT2A KPNA2 ARID4A ATAD2 PBRM1 CSN2 BRD4 SMARCA4 PRDM15 ZMYM4 RBM34	1.02e-05	495	222	18	int:H3C3
Interaction	EPB41L3 interactions	MCAM MECOM CUL7 RTF1 PPIG ARL13B TCF4 AKAP5 RFWD3 CD6 ACIN1 SNAI1 OCLN	1.08e-05	272	222	13	int:EPB41L3
Interaction	KLF5 interactions	MAZ KMT2C SEC16A LARP1 KMT2D PBRM1 BRD4 RBM6 HCFC1 ZMYM4 RBM34	1.12e-05	195	222	11	int:KLF5
Interaction	CREBBP interactions	UIMC1 MECOM KPNA6 KDM6B PPP1R13L KAT2B PAPOLA KMT2A SERTAD3 KPNA2 ZEB1 CEP290 TXNDC11 TRIM33 KMT2D BRD4 MED25 SMARCA4 SNAI1 TP53BP1	1.14e-05	599	222	20	int:CREBBP
Interaction	CLTC interactions	CYLD SLK MECOM CUL7 SYNJ1 SEC16A DSCAM HTR6 TROAP AAK1 STAM PRRT2 TRIM33 BRD4 HGS EIF4G1 TNK2 OCLN GGA1 PCM1 PINK1	1.25e-05	655	222	21	int:CLTC
Interaction	FEV interactions	MECOM RREB1 KMT2C PHC3 KMT2A ZEB1 SOX13 KMT2D PBRM1 ZFHX4 ZMYM4	1.63e-05	203	222	11	int:FEV
Interaction	SMAD1 interactions	MED14 MECOM KDM6B AXIN2 KAT2B BUB1 ZEB1 MED9 KMT2D HGS MED25 HCFC1	1.71e-05	243	222	12	int:SMAD1
Interaction	CENPA interactions	JADE3 MAZ BCORL1 MECOM KPNA6 ZNF362 RREB1 RTF1 CDCA2 KMT2A CENPT ATAD2 PBRM1 HCFC1 RBM34	2.02e-05	377	222	15	int:CENPA
Interaction	KLF15 interactions	MAZ BCORL1 KMT2C KAT2B SEC16A NRF1 LARP1 KMT2D PBRM1 SNAI1 ZMYM4 RBM34 RAI2	2.13e-05	290	222	13	int:KLF15
Interaction	ACLY interactions	CYLD CUL7 KAT2B MAGED2 SEC16A KPNA2 AAK1 TRIM33 MAPK15 BRD4 HGS EIF4G1 SNAI1 PINK1	2.24e-05	335	222	14	int:ACLY
Interaction	SIRT6 interactions	MED14 KPNA6 DHX9 CDCA2 SBF1 MAGED2 UBR5 SEC16A NKTR KPNA2 TROAP FNBP4 LMTK2 LARP1 PBRM1 PRPF3 BRD4 RBM6 SMARCA4 TP53BP1	2.24e-05	628	222	20	int:SIRT6
Interaction	PNMA2 interactions	CYLD KATNB1 CUL7 KDM6B MYO5C PPIG SBF1 UBR5 CEP290 CAMSAP3 TRIM33 DUSP10	2.36e-05	251	222	12	int:PNMA2
Interaction	DDX23 interactions	CAAP1 SLK JADE3 CUL7 RTF1 PPIG UBR5 NKTR KPNA2 CEP164 SART1 PRPF3 BRD4 RBM6 ACIN1 PCM1 RBM34	2.52e-05	480	222	17	int:DDX23
Interaction	NUP50 interactions	KPNA6 CDCA2 KMT2A DLG1 KPNA2 ZEB1 FNBP4 TRIM33 PBRM1 BRD4 EIF4G1 RBM6 TTI1 TP53BP1	2.72e-05	341	222	14	int:NUP50
Interaction	ACTN1 interactions	CAAP1 PCP2 SYNPO2L MED14 DDN CUL7 KAT2B UBR5 KPNA2 DSCAM LARP1 NR1H3 TRIM33 BRD4	2.72e-05	341	222	14	int:ACTN1
Interaction	PHF21A interactions	BCORL1 MECOM RREB1 ANKHD1 SYNJ1 UBR5 BUB1 SEC16A CCHCR1 ATG2B KMT2D ZFHX4 BRD4 PCM1	2.90e-05	343	222	14	int:PHF21A
Interaction	PPP1CA interactions	SLK SYNPO2L MECOM CUL7 PPP1R3G PPP1R13L MYO5C CDCA2 UBR5 KPNA2 CAMSAP3 AAK1 LMTK2 LARP1 PPP1R13B CAVIN3 STAM ZC3H7A BRD4 CCDC181 HCFC1	3.08e-05	696	222	21	int:PPP1CA
Interaction	LHX2 interactions	BCORL1 RREB1 KMT2C SINHCAF KMT2D PBRM1 ZFHX4 SMARCA4 ZMYM4 RBM34	3.70e-05	183	222	10	int:LHX2
Interaction	AR interactions	MED14 ZNF362 RREB1 MYO5C DHX9 CDCA2 KMT2C KAT2B UBR5 SEC16A KMT2A KPNA2 TCF4 LARP1 SART1 TRIM33 KMT2D PBRM1 PRPF3 BRD4 SMARCA4 ACIN1 TNK2 HCFC1 ZMYM4 PCM1	3.85e-05	992	222	26	int:AR
Interaction	MED30 interactions	MED14 MED9 BRD4 HGS MED25 PBXIP1 TP53BP1	3.95e-05	84	222	7	int:MED30
Interaction	CHD4 interactions	SLK MECOM KPNA6 CUL7 ANKHD1 DHX9 HOXA2 KMT2A KPNA2 DSG1 FNBP4 LARP1 TRAPPC8 SART1 PBRM1 ZFHX4 PRPF3 BRD4 EIF4G1 SMARCA4 ACIN1 SNAI1 ZMYM4 RBM34 PINK1	4.18e-05	938	222	25	int:CHD4
Interaction	LHX6 interactions	BCORL1 ZEB1 NRF1 ATG2B TRIM33 PBRM1	4.19e-05	58	222	6	int:LHX6
Interaction	KLF3 interactions	BCORL1 MECOM RREB1 KAT2B SINHCAF KMT2A ZEB1 ARID4A KMT2D PBRM1 ZMYM4	4.76e-05	228	222	11	int:KLF3
Interaction	H2AC4 interactions	MAZ KPNA6 ANKHD1 DHX9 KMT2C KAT2B PRDM10 UBR5 KMT2A SART1 KMT2D PBRM1 PRPF3 BRD4 HCFC1 TP53BP1 PINK1	4.88e-05	506	222	17	int:H2AC4
Interaction	SUPT5H interactions	MED14 CUL7 RTF1 PAPOLA UBR5 KMT2A DSCAM CEP290 TNS2 SART1 KMT2D BRD4 ACIN1 ZMYM4 PCM1	5.01e-05	408	222	15	int:SUPT5H
Interaction	CDK19 interactions	MED14 MYCBPAP MED9 MED25 SMARCA4 PBXIP1 TP53BP1	5.34e-05	88	222	7	int:CDK19
Interaction	CSNK2A1 interactions	MAZ MECOM CUL7 RTF1 KAT2B KMT2A NKTR ZEB1 NRF1 FNBP4 LARP1 E4F1 ATAD2 CD5 CD6 CSN2 BRD4 HGS SMARCA4 ACIN1 SNAI1 OCLN GGA1 HCFC1 RBM34	5.68e-05	956	222	25	int:CSNK2A1
Interaction	H3C14 interactions	MECOM CUL7 KMT2C KAT2B KMT2A ARID4A KMT2D BRD4 SMARCA4	5.97e-05	156	222	9	int:H3C14
Interaction	H3C1 interactions	UIMC1 MED14 MECOM KDM6B CDCA2 KMT2C KAT2B KMT2A AKAP5 CENPT CEP290 LARP1 ATAD2 TRIM33 KMT2D PBRM1 PRPF3 BRD4 EIF4G1 SMARCA4 SNAI1 ZMYM4 RBM34 TP53BP1	6.05e-05	901	222	24	int:H3C1
Interaction	TXNL4B interactions	TCF4 PRPF3 BRD4 ZMYM4 AHNAK2	6.58e-05	39	222	5	int:TXNL4B
Interaction	CSNK2B interactions	JADE3 MECOM CUL7 KDM6B SINHCAF KMT2A MICAL3 NKTR DSCAM NRF1 FBXL17 ATAD2 MADD RFWD3 CSN2 BRD4 OCLN HCFC1 ZMYM4	6.73e-05	625	222	19	int:CSNK2B
Interaction	PPP1CB interactions	SLK PPP1R13L MYO5C DHX9 HOXA2 CDCA2 PAPOLA SEC16A LMTK2 LARP1 PPP1R13B SIPA1 BRD4 EIF4G1 RBM6 HCFC1	6.82e-05	469	222	16	int:PPP1CB
Interaction	PIP4K2C interactions	SLK RTF1 LARP1 MADD RFWD3 TRIM33 CD6 BRD4 PINK1	6.92e-05	159	222	9	int:PIP4K2C
Interaction	JUN interactions	CYLD MAZ MECOM PPP1R13L DHX9 KMT2C KAT2B KPNA2 TCF4 AKAP5 BATF2 TRIM33 BRD4 RBM6 GGA1 HCFC1	7.00e-05	470	222	16	int:JUN
Interaction	SSRP1 interactions	JADE3 MECOM CUL7 KDM6B DHX9 RTF1 SBF1 UBR5 KMT2A LMTK2 TRAPPC8 CEP164 SART1 TRIM33 PBRM1 PRPF3 BRD4 SMARCA4 ACIN1 HCFC1	7.52e-05	685	222	20	int:SSRP1
Interaction	KLF9 interactions	ANKHD1 CDCA2 SINHCAF SEC16A ARID4A PBRM1 RBM34	7.60e-05	93	222	7	int:KLF9
Interaction	SIRT7 interactions	CUL7 ANKHD1 KAT2B SBF1 UBR5 SEC16A KMT2A AFDN LARP1 ATAD2 SART1 PBRM1 BRD4 EIF4G1 RBM6 SMARCA4 ACIN1 HCFC1 PCM1 RBM34 TP53BP1	7.99e-05	744	222	21	int:SIRT7
Interaction	SNRNP40 interactions	JADE3 KPNA6 ZNF362 CUL7 CDCA2 PHC3 PRDM10 UBR5 KMT2A NKTR CENPT DSG1 ATAD2 SART1 PRPF3 BRD4 RBM6 SMARCA4 ACIN1	8.64e-05	637	222	19	int:SNRNP40
Interaction	LHX4 interactions	KMT2C ADAMTSL4 TCF4 NRF1 TRIM33 KMT2D PBRM1 SMARCA4 ZMYM4	9.64e-05	166	222	9	int:LHX4
Interaction	SMAD2 interactions	MECOM KDM6B KMT2C KAT2B PAPOLA UBR5 AFDN ZEB1 MED9 TRIM33 HGS MED25 SMARCA4 HCFC1	1.00e-04	385	222	14	int:SMAD2
Interaction	SAP30 interactions	PHC3 SINHCAF KMT2A BAHCC1 ARID4A FNBP4 BRD4 SMARCA4 HCFC1	1.01e-04	167	222	9	int:SAP30
Interaction	MED15 interactions	MED14 RTF1 KMT2A MED9 BRD4 MED25 HCFC1 TP53BP1	1.04e-04	131	222	8	int:MED15
Interaction	FBXO22 interactions	CYLD GC KPNA6 RTF1 KMT2C KMT2A C4A MICAL3 C4B TAPBP CAMSAP3 FNBP4 SART1 SNAI1 HCFC1 RBM34 TP53BP1	1.08e-04	540	222	17	int:FBXO22
Interaction	MED14 interactions	MED14 RTF1 UBR5 KMT2A MED9 FBXL17 BRD4 MED25 TP53BP1	1.21e-04	171	222	9	int:MED14
Interaction	SUPT16H interactions	MECOM CUL7 DHX9 RTF1 SBF1 UBR5 NKTR LMTK2 CEP164 TRIM33 PRPF3 BRD4 SMARCA4 ACIN1 PINK1	1.22e-04	442	222	15	int:SUPT16H
Interaction	PARP1 interactions	CYLD UIMC1 BCORL1 MED14 MECOM ZNF362 CUL7 RREB1 HOXA2 RTF1 CDCA2 PHC3 KAT2B TCF4 ZEB1 NRF1 DSG1 LMTK2 E4F1 ATAD2 SART1 TRIM33 PBRM1 BRD4 SMARCA4 SNAI1 ZMYM4 RBM34 TP53BP1 PINK1	1.22e-04	1316	222	30	int:PARP1
Interaction	MED6 interactions	MED14 UBR5 MED9 BRD4 MED25 SMARCA4 TP53BP1	1.28e-04	101	222	7	int:MED6
Interaction	ING1 interactions	KAT2B SINHCAF BAHCC1 KPNA2 ARID4A CAMSAP3 SMARCA4	1.45e-04	103	222	7	int:ING1
Interaction	TOP3B interactions	PPRC1 MED14 KDM6B ZNF236 ANKHD1 AXIN2 DHX9 C2CD2L KMT2C SBF1 SYNJ1 SEC16A MICAL3 ADAMTSL4 WNK2 BAHCC1 ZNF628 NRF1 SZT2 LMTK2 LARS2 MADD ZC3H7A KMT2D BRD4 EIF4G1 ACIN1 TNK2 GGA1 HCFC1 TP53BP1 AHNAK2	1.67e-04	1470	222	32	int:TOP3B
Interaction	H2BC3 interactions	CYLD DHX9 HOXA2 KMT2C KAT2B MAGED2 KMT2A MTERF3 KMT2D PBRM1 PRPF3 BRD4 TP53BP1 PINK1	1.74e-04	406	222	14	int:H2BC3
Interaction	CDK8 interactions	MED14 KAT2B BUB1 SEC16A MED9 MED25 SMARCA4 PBXIP1 ZMYM4 TP53BP1	1.84e-04	222	222	10	int:CDK8
Interaction	YAP1 interactions	SLK MED14 DDN DHX9 RTF1 KMT2C PAPOLA SEC16A KMT2A DLG1 AFDN KPNA2 TMEM139 ZEB1 FNBP4 LARP1 SH3D21 TAB3 KMT2D BRD4 SMARCA4 ACIN1 SNAI1 HCFC1 ZMYM4 PINK1	1.91e-04	1095	222	26	int:YAP1
Interaction	PEF1 interactions	SEC16A FBXL17 CEP164 BRD4 HGS EIF4G1 MED25	1.95e-04	108	222	7	int:PEF1
Interaction	FOXK2 interactions	SINHCAF PRDM10 NRF1 ARID4A KMT2D CD6 BRD4 DNAI2 HCFC1 TP53BP1	2.05e-04	225	222	10	int:FOXK2
Interaction	SNRPB interactions	CAAP1 CUL7 DHX9 PPIG MICAL3 NKTR SERTAD3 AKAP5 CEP290 FNBP4 SART1 PRPF3 BRD4 ACIN1 SNAI1 HCFC1	2.09e-04	517	222	16	int:SNRPB
Interaction	PAX6 interactions	RREB1 KMT2C SINHCAF SYNJ1 DLG1 ZEB1 DSCAM KMT2D PBRM1 ZFHX4 HGS SMARCA4 ZMYM4	2.23e-04	366	222	13	int:PAX6
Interaction	ELF5 interactions	DHX9 KMT2C KPNA2 SART1 TRIM33 KMT2D PBRM1 HCFC1	2.30e-04	147	222	8	int:ELF5
Interaction	GART interactions	CUL7 KDM6B KPNA2 TRIM33 ZC3H7A PBRM1 BRD4 SNAI1 HCFC1 PINK1	2.45e-04	230	222	10	int:GART
Interaction	CCNC interactions	MED14 SERTAD3 CCHCR1 MED9 LCN2 BRD4 MED25 PBXIP1 TP53BP1	2.46e-04	188	222	9	int:CCNC
Interaction	IMPDH2 interactions	CYLD SLK CUL7 JMY MYO5C SYNJ1 SEC16A MED9 ATG2B AAK1 LARP1 BRD4 SNAI1 PINK1	2.47e-04	420	222	14	int:IMPDH2
Interaction	H3-3A interactions	UIMC1 MAZ BCORL1 ZNF362 RREB1 KDM6B CDCA2 KMT2C KAT2B KMT2A CENPT ATAD2 KMT2D PBRM1 BRD4 SMARCA4 PRDM15 HCFC1 ZMYM4 RBM34	2.47e-04	749	222	20	int:H3-3A
Interaction	HNF1B interactions	KMT2C KAT2B SINHCAF ZEB1 SOX13 KMT2D PBRM1 ZFHX4 ZMYM4	2.66e-04	190	222	9	int:HNF1B
Interaction	PML interactions	UIMC1 MCAM ZNF280B PPP1R13L MAGED2 UBR5 SEC16A KMT2A ACOT8 MAMLD1 AAK1 LARP1 STAM SART1 TRIM33 PRPF3 BRD4 EIF4G1 SMARCA4 HCFC1 ZMYM4 TP53BP1 AHNAK2	2.68e-04	933	222	23	int:PML
Interaction	PHF20 interactions	JADE3 KDM6B KMT2C KMT2A HCFC1	2.89e-04	53	222	5	int:PHF20
Interaction	MYOD1 interactions	KMT2C KAT2B SINHCAF TCF4 ZEB1 TRIM33 KMT2D PBRM1 SMARCA4	3.11e-04	194	222	9	int:MYOD1
Interaction	E2F4 interactions	MCAM PPP1R13L JMY MAGED2 KMT2A MICAL3 PPP1R13B ATAD2 SART1 BRD4 EIF4G1 SMARCA4 ACIN1 HCFC1 PCM1 TP53BP1	3.39e-04	540	222	16	int:E2F4
Interaction	E2F2 interactions	JMY KMT2A PPP1R13B ATAD2 KMT2D	3.45e-04	55	222	5	int:E2F2
Interaction	MED22 interactions	MED14 MED9 BRD4 HGS MED25 TP53BP1	3.54e-04	85	222	6	int:MED22
Interaction	POLR1G interactions	JADE3 BCORL1 ZNF362 RREB1 RTF1 CDCA2 PHC3 KMT2A KPNA2 PBRM1 CD6 BRD4 SMARCA4 ZMYM4 RBM34	3.61e-04	489	222	15	int:POLR1G
Interaction	MED13 interactions	MED14 TSC22D2 MED9 BRD4 MED25 TP53BP1	3.77e-04	86	222	6	int:MED13
Interaction	MED17 interactions	SLK MED14 KMT2A MED9 MTERF3 BRD4 MED25 SMARCA4 TP53BP1	4.18e-04	202	222	9	int:MED17
Interaction	NHLH1 interactions	CDCA2 KMT2A TCF4 ZEB1 KMT2D RBM34	4.27e-04	88	222	6	int:NHLH1
Interaction	CYTOR interactions	DHX9 DSG1 EIF4G1	4.39e-04	14	222	3	int:CYTOR
Interaction	MEN1 interactions	MED14 KPNA6 DHX9 KMT2C PAPOLA UBR5 KMT2A AFDN C4A KPNA2 FNBP4 LARP1 ATAD2 SART1 KMT2D PBRM1 PRPF3 EIF4G1 SMARCA4 ACIN1 HCFC1 ZMYM4 RBM34 TP53BP1	4.40e-04	1029	222	24	int:MEN1
Interaction	DPY30 interactions	UIMC1 KMT2C UBR5 KMT2A KMT2D PRPF3 BRD4 HCFC1 TP53BP1	4.49e-04	204	222	9	int:DPY30
Interaction	PAX7 interactions	SLK RREB1 KMT2C SINHCAF ZEB1 KMT2D ZFHX4	4.53e-04	124	222	7	int:PAX7
Interaction	ATG5 interactions	CYLD ANKHD1 DHX9 SBF1 SYNJ1 MAGED2 SEC16A CCHCR1 ATG2B AAK1 TAB3 PINK1	4.56e-04	344	222	12	int:ATG5
Interaction	ASF1A interactions	BCORL1 ZNF362 RREB1 CDCA2 KMT2A NRF1 TRIM33 KMT2D SMARCA4 HCFC1	4.59e-04	249	222	10	int:ASF1A
Interaction	STX6 interactions	SYNJ1 ARL13B SEC16A DLG1 RELCH LMTK2 SCAMP2 STAM PRRT2 TRAPPC8 HGS OCLN PBXIP1 AHNAK2	4.72e-04	448	222	14	int:STX6
Interaction	FHL2 interactions	CYLD PHC3 SINHCAF BAHCC1 NRF1 ARID4A NBPF6 E4F1 CSN2 DUSP10 SNAI1 ZMYM4 RAI2	4.73e-04	396	222	13	int:FHL2
Interaction	BICD1 interactions	CYLD SYNJ1 UBR5 DSCAM AAK1 CEP164 TAB3 HGS GGA1 PCM1	4.74e-04	250	222	10	int:BICD1
Interaction	MED4 interactions	CYLD SLK MED14 UBR5 MICAL3 CCHCR1 MED9 CEP290 ATG2B BRD4 HGS MED25 PCM1 TP53BP1	4.93e-04	450	222	14	int:MED4
Interaction	SON interactions	MECOM CUL7 DHX9 UBR5 NKTR PRPF3 BRD4 ACIN1 PINK1	5.16e-04	208	222	9	int:SON
Interaction	SRSF4 interactions	PPIG PRDM10 UBR5 KMT2A NKTR MTERF3 LARP1 SART1 ACIN1 PRDM15 PINK1	5.19e-04	300	222	11	int:SRSF4
Cytoband	12q13.12	DDN FAM186A TROAP KMT2D	3.77e-05	38	227	4	12q13.12
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	MECOM KMT2C KMT2A KMT2D	1.45e-04	34	143	4	487
GeneFamily	ESCRT-0	STAM HGS	1.85e-04	3	143	2	1115
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	MECOM PRDM10 PRDM15	3.04e-04	17	143	3	1197
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	PPP1R3G CDCA2 CAMSAP3 LMTK2 PPP1R13B OCLN HCFC1	5.98e-04	181	143	7	694
GeneFamily	PHD finger proteins	JADE3 KMT2C KMT2A TRIM33 KMT2D	7.40e-04	90	143	5	88
GeneFamily	PDZ domain containing	SYNPO2L DLG1 AFDN SIPA1 PRX AHNAK2	1.33e-03	152	143	6	1220
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B	2.16e-03	9	143	2	1234
GeneFamily	Cyclins\|Mediator complex	MED14 MED9 MED25	2.22e-03	33	143	3	1061
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKG DGKI	2.68e-03	10	143	2	1178
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	CYLD MED14 JMY DHX9 PHC3 SINHCAF NKTR ZEB1 FNBP4 FBXL17 E4F1 CD6 PRPF3 DUSP10 OCLN RBM34	3.83e-06	474	225	16	M40991
ToppCell	nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	JMY KAT2B ZEB1 CD177 STAM BICDL1 CD5 CD6 DUSP10 PBXIP1	3.94e-08	185	226	10	a86a3a1a187a4d8d7762bc6d3dcb22c982178d22
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	JADE3 MED14 RTF1 PHC3 PPIG PRDM10 ARID4A TRIM33 PBRM1 HMCN1	4.14e-08	186	226	10	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	KPNA6 KMT2A NKTR TCF4 TROAP AAK1 LARP1 BRD4 HGS AHNAK2	5.59e-08	192	226	10	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	MAZ KDM6B KMT2A WNK2 RALGDS CAMSAP3 PRRT2 ARHGDIG ZFHX4 CALY	8.19e-08	200	226	10	c92e4fc0442404481fcac623d691dae6215b852d
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MECOM KMT2C UBR5 KMT2A AFDN NKTR TCF4 ZEB1 HMCN1 TNK2	8.19e-08	200	226	10	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYLD JMY TMEM156 NKTR WNK2 ZEB1 CD5 CD6 PBXIP1	1.95e-07	167	226	9	83969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF236 CCDC88B WNK2 CD177 LCN2 HEXD TAB3 DGKI FRMD3	2.16e-07	169	226	9	bca5322880c09b78ef10d9dda6420a80c1ba7e62
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JADE3 MCAM MECOM PRDM10 ZEB1 CAVIN3 SOX13 BICDL1 HMCN1	2.27e-07	170	226	9	8fe32dcf924d5f6665f7febbc9647d96b1e96f06
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JADE3 MCAM MECOM PRDM10 ZEB1 CAVIN3 SOX13 BICDL1 HMCN1	2.27e-07	170	226	9	3232db50b1a40f861e981a1b9c9073b81af9f832
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JADE3 MCAM MECOM PRDM10 ZEB1 CAVIN3 SOX13 BICDL1 HMCN1	2.27e-07	170	226	9	50c6c571591aa4b218caefe5778c570c809f567e
ToppCell	Control-Lymphoid-T_Regulatory\|World / Disease state, Lineage and Cell class	JMY KAT2B ZEB1 CD177 STAM BICDL1 CD5 CD6 PBXIP1	3.68e-07	180	226	9	47036eee4c128fbb443d1fc767b4de5cced93f0e
ToppCell	Control-Lymphoid-T_Regulatory\|Control / Disease state, Lineage and Cell class	JMY KAT2B ZEB1 CD177 STAM BICDL1 CD5 CD6 PBXIP1	4.04e-07	182	226	9	31bb838cc2900f3c9da9f835d79d557a08abb928
ToppCell	IPF-Lymphoid-T_Regulatory\|IPF / Disease state, Lineage and Cell class	JMY KAT2B ZEB1 CD177 STAM BICDL1 CD5 CD6 PBXIP1	4.64e-07	185	226	9	221cbd09d94cc0947d0e3c1aa14716d17cb2068d
ToppCell	normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	DGKG TSC22D2 SNX19 CENPT MAMLD1 RLN1 TTI1 PBXIP1	9.70e-07	149	226	8	a34d095b8e0fe59d69d84e4fd2fe4ccb82f92e4f
ToppCell	severe_COVID-19-MAIT\|severe_COVID-19 / disease group, cell group and cell class (v2)	SYNPO2L MCAM PPP1R13L TMEM266 PRRT2 LARS2 BICDL1 DUSP10	1.44e-06	157	226	8	175f637e9707836bd63b5c2ccc9d4eb601c05b9e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AXIN2 KMT2A NKTR ZEB1 AAK1 BICDL1 CD5 CD6	4.69e-06	184	226	8	5350b58aa9979631228835d11eb45ddf81d08bff
ToppCell	IPF-Lymphoid-T_Regulatory\|World / Disease state, Lineage and Cell class	JMY KAT2B ZEB1 CD177 STAM ZC3H7A BICDL1 PBXIP1	4.88e-06	185	226	8	77fbecdab10bacc005b1c7e22ca414cfecef13c1
ToppCell	COPD-Lymphoid-T_Regulatory\|COPD / Disease state, Lineage and Cell class	JMY KAT2B ZEB1 CD177 STAM ZC3H7A BICDL1 PBXIP1	4.88e-06	185	226	8	846403edd4c8f646201d519055198fc38b7ffff9
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MCAM MECOM CENPT TNS2 CCDC80 CAVIN3 OCLN FRMD3	5.28e-06	187	226	8	12129e02638c20d9b7c1c6e512d48bfd966e1029
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MCAM MECOM CENPT TNS2 CCDC80 CAVIN3 OCLN FRMD3	5.28e-06	187	226	8	83930ef55191eff9006113feaeabb3c2fa21fd05
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-Tregs\|Lung / Manually curated celltypes from each tissue	JMY MYO5C ZEB1 CD177 STAM BICDL1 CD5 PBXIP1	5.49e-06	188	226	8	604f340052807bd902915eca942a97ccc36b42e0
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	MECOM PCDH15 TCF4 SASH1 HMCN1 ZNF804B DGKI IRAK3	5.71e-06	189	226	8	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	MECOM PCDH15 TCF4 ZEB1 SASH1 HMCN1 DGKI IRAK3	5.71e-06	189	226	8	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFDN NPPC ADAMTS2 LRRC10 LMTK2 TNS2 DMBX1 HMCN1	5.71e-06	189	226	8	d00410010283dc6191ce9857d6c7952678fed588
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	JMY TMEM156 ZEB1 ZC3H7A BICDL1 CD5 CD6 PBXIP1	5.93e-06	190	226	8	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCAM SASH1 PPP1R13B LARS2 SOX13 PRX HMCN1 OCLN	6.91e-06	194	226	8	f159ef8541d75a4e98468947f231bb463bec922c
ToppCell	BL-critical-LOC-Lymphoid-CTL\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TMEM156 KMT2A NKTR FNBP4 AAK1 CD5 CD6 PBXIP1	7.73e-06	197	226	8	fb70918867fbd111bb192a797dcafed5f39ea299
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	RTF1 PPIG NKTR ZEB1 ARID4A CEP290 CEP164 GGA1	7.73e-06	197	226	8	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	RTF1 PPIG SEC16A KPNA2 CEP290 AAK1 TRIM33 BRD4	8.02e-06	198	226	8	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	severe_COVID-19-MAIT\|World / disease group, cell group and cell class (v2)	SYNPO2L MCAM PPP1R13L TMEM266 PRRT2 LARS2 DUSP10	1.40e-05	154	226	7	65ec7f7ef05c589903c4c9fe3849478c325fdc61
ToppCell	BL-critical-LOC-Epithelial-FOXN4+\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SAMD15 FER1L6 MYO5C TMEM266 CLBA1 LCN2 CCDC181	1.79e-05	160	226	7	3f737451d5713deed20061aa72a9ef77a9a2bc06
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AXIN2 DHX9 NKTR ZEB1 BICDL1 CD5 CD6	1.94e-05	162	226	7	80317c4253bf8e897782e562f29835f181c65b98
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAZ AAK1 STAM BICDL1 CD5 CD6 PBXIP1	2.02e-05	163	226	7	4dfd408aa700e307478ee35f6b902f68719d8d9e
ToppCell	facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAZ AXIN2 KAT2B CCHCR1 SZT2 FBXL17 BICDL1	2.10e-05	164	226	7	1d0d88132baaa3154c3e6e4ef0aff795afab08a2
ToppCell	facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAZ AXIN2 KAT2B CCHCR1 SZT2 FBXL17 BICDL1	2.10e-05	164	226	7	bd2e10b015d5e6a338675500ec5d81dc39583b3e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CDCA2 BUB1 CLEC19A TCF4 TROAP ATAD2 RFWD3	2.36e-05	167	226	7	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	CYLD KDM6B JMY NKTR AAK1 BICDL1 PCM1	2.74e-05	171	226	7	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KATNB1 CDCA2 MAMLD1 NR1H3 CAVIN3 HMCN1 FRMD3	3.06e-05	174	226	7	1d157f7a919c8246e83d8060d2a0017c6c781ef3
ToppCell	15-Trachea-Epithelial-Goblet-like_secretory\|Trachea / Age, Tissue, Lineage and Cell class	WNK2 ZG16B CAVIN3 LCN2 BATF2 CREB3L1 HERPUD1	3.54e-05	178	226	7	f0557920b9b3e7c4f39938d1b524aa58711af4d2
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF362 KMT2A NKTR ZEB1 CD5 CD6 PBXIP1	3.54e-05	178	226	7	f94e306b9550f3d1b5de0bb806790c17823d439e
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLK FER1L6 MYO5C DLG1 NKTR WNK2 LMTK2	3.67e-05	179	226	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HOXA2 MAGED2 MICAL3 POM121L2 NR1H3 CREB3L1 SNAI1	3.67e-05	179	226	7	b559f5a72cc9e3e35d05cb539b5c2e006e56e652
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ISM2 HTR6 PRX RLN1 ZNF804B	3.72e-05	74	226	5	195fd37345a394c0b60f713bedadf6fd08dc050c
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ISM2 HTR6 PRX RLN1 ZNF804B	3.72e-05	74	226	5	c68b00cf7d2cec7951b78e2c6710d7770b02566a
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ISM2 HTR6 PRX RLN1 ZNF804B	3.72e-05	74	226	5	bad24c9251ef44c05f3390073732a467aaeefe1e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	AXIN2 AAK1 BICDL1 CD5 CD6 CALY PBXIP1	3.80e-05	180	226	7	f3d35b2ea78afef37a84232adf5e6e26712b618d
ToppCell	COPD-Lymphoid-T_Regulatory\|World / Disease state, Lineage and Cell class	JMY KAT2B ZEB1 CD177 STAM BICDL1 PBXIP1	3.80e-05	180	226	7	51a12fbad5fa7bb12e6d616a02ff9b5141e2b063
ToppCell	droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IMPG1 CDCA2 BUB1 TROAP PKD1L3 CD5 CD6	3.94e-05	181	226	7	74311aac2fe27dc02a9be3bc20e0c7ef1c239049
ToppCell	droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IMPG1 CDCA2 BUB1 TROAP PKD1L3 CD5 CD6	3.94e-05	181	226	7	cf13bf7a531a2d40f8d778629cf2431b684f65f3
ToppCell	NS-critical-d_0-4-Lymphoid-Treg\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MCAM KMT2A AAK1 CD5 CD6 RBM6 PBXIP1	4.22e-05	183	226	7	f478dfa231fc1b12ead0183cc9d22077cdf43d1f
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells-Erythroid\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKRD31 MAMLD1 KIAA1549 PKD1L3 CD5 CD6	4.48e-05	126	226	6	54247ce9ee0a4f123f1fb225600a4ec698510a86
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	BUB1 KMT2A NKTR ZEB1 CD5 CD6 PBXIP1	4.53e-05	185	226	7	f1263899a2d41d182022dc4ca62cbae08a463c89
ToppCell	P15-Epithelial-airway_epithelial_cell-club_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GGT6 MYCBPAP ARHGDIG MAPK15 DNAI2 CFAP61 NEK11	4.84e-05	187	226	7	a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40
ToppCell	droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Scara5+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C4B ADAMTSL4 ADAMTS2 CCDC80 NR1H3 CAVIN3 IRAK3	4.84e-05	187	226	7	7beba2a5d5978f2ae7d8bde10815705cf2572211
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	DGKG PPP1R13L MICAL3 WNK2 AAK1 PPP1R13B CFAP61	5.01e-05	188	226	7	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	KDM6B JMY TMEM156 SINHCAF ZEB1 BICDL1 CD6	5.01e-05	188	226	7	939790f133eac9c12d08db6ddb5f08f5107844e3
ToppCell	P15-Epithelial-airway_epithelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GGT6 MYCBPAP ARHGDIG MAPK15 DNAI2 CFAP61 NEK11	5.01e-05	188	226	7	e3e71c0f2e374330620cb4d27638953ffa9f5298
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYLD AXIN2 TMEM156 BICDL1 CD5 CD6 PBXIP1	5.18e-05	189	226	7	8130102c41b2978a8b83f765ce383f836a464795
ToppCell	ASK452-Immune-T_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	RBM44 C2CD2L TMEM156 CD5 CD6 RBM6 PBXIP1	5.18e-05	189	226	7	f5dc500f77f04a110dd4a65cf4c03068a495dbdb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDCA2 BUB1 TCF4 TROAP ZG16B ATAD2 RFWD3	5.36e-05	190	226	7	31de1727822e9818652946dfb962daee77ffad68
ToppCell	facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGT6 MYCBPAP ARHGDIG MAPK15 DNAI2 CFAP61 NEK11	5.36e-05	190	226	7	fe844559b95832845d2e8d3ab4b57e3d558bc372
ToppCell	facs-Lung-nan-3m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGT6 MYCBPAP ARHGDIG MAPK15 DNAI2 CFAP61 NEK11	5.36e-05	190	226	7	e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	SECISBP2L MECOM MYO5C AFDN DSCAM PPP1R13B OCLN	5.54e-05	191	226	7	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L TMEM156 MICAL3 TCF4 ZEB1 CLEC17A HERPUD1	5.72e-05	192	226	7	446c61c0d6ba89c619efe87ee495951299953981
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCERG1L GC PCDH15 DSCAM ZFHX4 CALY PBXIP1	5.72e-05	192	226	7	550a6574a93acadb43c449094565c73ca51a0c5c
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	KMT2C KMT2A NKTR AAK1 BICDL1 CD6 PCM1	5.72e-05	192	226	7	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	Ciliated-cil-3\|World / Class top	CD177 PPP1R13B ARHGDIG MAPK15 DNAI2 CFAP61 CCDC181	5.72e-05	192	226	7	4989ebb8812b8af1870599acd932849122c05a29
ToppCell	NS-moderate-d_16-33-Lymphoid-Treg\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MCAM TMEM156 NKTR AAK1 CD5 CD6 PBXIP1	5.72e-05	192	226	7	48d557071bad80edd3ec6e5ad8dcd97037da9553
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	MECOM TCF4 ZEB1 SASH1 ADAMTS2 CCDC80 FRMD3	5.72e-05	192	226	7	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GC AFDN ADAMTSL4 CAMSAP3 LMTK2 LARS2 HMCN1	5.91e-05	193	226	7	eba3c70701b051bc1ed1f4db9270cb27a77ffc3e
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GGT6 KATNB1 CDCA2 BUB1 TROAP ZG16B LCN2	5.91e-05	193	226	7	0ef076417ffe2dd1cbc2c3d1e35c7f8522af143b
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-Tregs\|blood / Manually curated celltypes from each tissue	JMY ZEB1 STAM CD5 DUSP10 HERPUD1 PBXIP1	5.91e-05	193	226	7	2ffe44edf2b02d11a7c10513692eb697a10f911e
ToppCell	Adult-Immune-T_lymphocyte\|Adult / Lineage, Cell type, age group and donor	TMEM156 KAT2B ZEB1 BICDL1 CD5 CD6 PBXIP1	5.91e-05	193	226	7	26df0c4c8a2355dd5503fadd07e368eb9a2bf06a
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L KDM6B MICAL3 TCF4 ZEB1 DUSP10 HERPUD1	5.91e-05	193	226	7	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CDCA2 MAGED2 BUB1 KPNA2 TROAP NR1H3 SNAI1	6.11e-05	194	226	7	d840c1949c328779426c9172e02da09e968f0567
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5C CDCA2 BUB1 TMEM139 TROAP LMOD3 PALM3	6.11e-05	194	226	7	d790cfff3664e46fe2fd2f6b0c26896799927845
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CDCA2 BUB1 KPNA2 ZEB1 TROAP ATAD2 RBM34	6.11e-05	194	226	7	7a66bd7d4fc9c6db861cedd2487f241e406869d1
ToppCell	Nasal_Brush\|World / Tissue, Lineage and Cell class of Lung Cells from 10X	FER1L6 TMEM139 ZG16B CCDC80 LCN2 CREB3L1 IRAK3	6.31e-05	195	226	7	7509b980b6b293df02bec619ef5b83a6c7b49c03
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CYLD KMT2A NKTR ZEB1 CD5 CD6 PBXIP1	6.31e-05	195	226	7	4bdedd924564a260841a9153604026b57487c83d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L TMEM156 MICAL3 TCF4 ZEB1 CLEC17A HERPUD1	6.31e-05	195	226	7	0c49d22c348aec6d8a1a976e7c88d0a3b48a4244
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CYLD TMEM156 ZEB1 CD177 CD5 CD6 PBXIP1	6.31e-05	195	226	7	6ddce0cce14f737e45b8f57802c6a8ad07686262
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_2\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	CYLD TMEM156 ZEB1 CD177 CD5 CD6 PBXIP1	6.31e-05	195	226	7	e6212373cc3c6c98f76e104e2ac1afa68965cc5f
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FER1L6 CD177 ZG16B LCN2 BATF2 CREB3L1 IRAK3	6.31e-05	195	226	7	3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2C SYNJ1 SEC16A KMT2A NKTR MADD PCM1	6.31e-05	195	226	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	JMY KMT2A TCF4 ZEB1 CD6 PBXIP1 PCM1	6.31e-05	195	226	7	ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell	Mild_COVID-19-T/NK-CD4+_T_2\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CYLD TMEM156 ZEB1 CD177 CD5 CD6 PBXIP1	6.52e-05	196	226	7	e50d03d8428dc4526e4607b6b4e99f0812a0ad31
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	CYLD KMT2C PPIG KAT2B MAGED2 KMT2A PBRM1	6.52e-05	196	226	7	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	moderate-Lymphoid-Treg\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MCAM NKTR TAPBP AAK1 BICDL1 CD6 PBXIP1	6.52e-05	196	226	7	9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TMEM266 AFDN TCF4 LRRC10 NBPF6 AHNAK2	6.58e-05	135	226	6	7743a01dc9c4542e910e7c0fe046004692a680bf
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TMEM156 KMT2A NKTR BICDL1 CD5 CD6 PBXIP1	6.73e-05	197	226	7	ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CYLD KMT2C KMT2A NKTR AAK1 SEC31B PCM1	6.73e-05	197	226	7	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLK GGT6 FER1L6 ZG16B CCDC80 LCN2 CREB3L1	6.73e-05	197	226	7	adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131
ToppCell	Transverse-(2)_B_cell-(21)_B_cell_IgG_Plasma\|Transverse / shred on region, Cell_type, and subtype	PPP1R3G TMEM156 TCF4 TBC1D30 TEX14 TXNDC11 HERPUD1	6.94e-05	198	226	7	d6052b5a44246798e90f4779cd940ffac7539fcd
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TMEM156 KMT2A NKTR BICDL1 CD5 CD6 PBXIP1	6.94e-05	198	226	7	33a3b279c9ff3b762e52d060dae062167ca2239b
ToppCell	Transverse-B_cell-B_cell_IgG_Plasma\|Transverse / Region, Cell class and subclass	PPP1R3G TMEM156 TCF4 TBC1D30 TEX14 TXNDC11 HERPUD1	6.94e-05	198	226	7	a4ece1fe3d15acfde0e6ff14cddb3a3d16f61ce0
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MECOM KMT2C UBR5 DLG1 ZFAND3 FBXL17 RBM6	7.17e-05	199	226	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLK GGT6 FER1L6 ZG16B CCDC80 LCN2 CREB3L1	7.17e-05	199	226	7	0c060ef64341659f4b1247d0264ac12e53a7e12e
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GGT6 FER1L6 WNK2 CD177 ZG16B LCN2 CREB3L1	7.17e-05	199	226	7	a706ad5cd5e0dc8d7e925a05e45b07d35963f294
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLK GGT6 FER1L6 ZG16B CCDC80 LCN2 CREB3L1	7.17e-05	199	226	7	8bf8d7cd774479f065bbbbcb5a4bd1aa91aa0d85
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GGT6 FER1L6 MAGED2 ZG16B CCDC80 LCN2 CREB3L1	7.17e-05	199	226	7	1e693d7bb481bf03a943b460a69787229625d7b1
Drug	Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A	CYLD TSC22D2 BUB1 ZEB1 SZT2 TNS2 LCN2 SH3D21 MED25 TNK2 PCM1 RBM34 RAI2	9.36e-08	198	225	13	3842_UP
Drug	17-DMAG; Down 200; 0.1uM; HL60; HT_HG-U133A	BCORL1 DDN TSC22D2 SBF1 UBR5 BAHCC1 CENPT CEP290 BRD4 HCFC1 PCM1	4.08e-06	195	225	11	6172_DN
Drug	Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A	KATNB1 BUB1 MED9 AAK1 TNS2 SIPA1 SH3D21 DGKI HCFC1 NEK11 PINK1	4.50e-06	197	225	11	3540_UP
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	ZNF236 BUB1 KMT2A RALGDS ZEB1 AAK1 CREB3L1 TRIM33 SMARCA4 PBXIP1 HCFC1	4.50e-06	197	225	11	3748_DN
Drug	Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A	CUL7 YIPF2 SBF1 CLBA1 BAHCC1 DSCAM LARP1 TNS2 SIPA1 GGA1 PCM1	4.96e-06	199	225	11	2220_DN
Drug	Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A	AMACR LILRB1 KMT2A AFDN CLBA1 SZT2 TEX14 MED25 PBXIP1 HCFC1	1.63e-05	185	225	10	4445_UP
Drug	Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ZNF362 C2CD2L KMT2A AFDN MED25 TNK2 DUSP10 CCDC181 PBXIP1 HCFC1	1.87e-05	188	225	10	4405_UP
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	DHX9 PAPOLA UBR5 KMT2A SASH1 CEP290 MAMLD1 MADD EIF4G1 PBXIP1	1.87e-05	188	225	10	4845_DN
Drug	Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; HL60; HT_HG-U133A	KATNB1 ZNF236 C2CD2L PHC3 YIPF2 KMT2A TCF4 TBC1D30 CEP290 POM121L2	2.35e-05	193	225	10	3124_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	CYLD MED14 MECOM CUL7 CLBA1 SASH1 CEP164 ARHGDIG ZMYM4 AHNAK2	2.35e-05	193	225	10	1652_UP
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	CUL7 C2CD2L KMT2A RFWD3 TRIM33 GGA1 HCFC1 ZMYM4 PCM1 TP53BP1	2.46e-05	194	225	10	1670_DN
Drug	colchicine; Down 200; 1uM; SKMEL5; HG-U133A	PAPOLA KMT2A BAHCC1 TROAP TRIM33 ACIN1 TTI1 ZMYM4 PCM1 AHNAK2	2.57e-05	195	225	10	630_DN
Drug	Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	CYLD MCAM C2CD2L CLBA1 BAHCC1 MAMLD1 CEP164 CD6 TNK2 HCFC1	2.68e-05	196	225	10	2784_UP
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	DDN BUB1 AAK1 CEP164 TRIM33 MED25 TNK2 PBXIP1 NEK11 INPP5J	2.68e-05	196	225	10	3783_DN
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	CYLD KATNB1 PHC3 BAHCC1 ZFAND3 DSCAM NR1H3 RLN1 BRD4 AHNAK2	2.68e-05	196	225	10	1658_UP
Drug	Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A	GC PAPOLA BUB1 ZEB1 LMTK2 SIPA1 BRD4 DNAI2 PCM1 AHNAK2	2.80e-05	197	225	10	5456_UP
Drug	Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A	AMACR BCORL1 CUL7 SBF1 TCF4 CENPT SZT2 MADD SMARCA4 TNK2	2.80e-05	197	225	10	4606_DN
Drug	N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A	KATNB1 DDN CUL7 KDM6B SYNJ1 TCF4 CREB3L1 ARHGDIG CD6 RBM34	2.80e-05	197	225	10	6732_DN
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	KATNB1 KMT2A CLBA1 ZEB1 CEP290 LMTK2 CD6 DNAI2 MED25 AHNAK2	2.80e-05	197	225	10	4968_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA	SECISBP2L JADE3 KPNA6 ZNF236 RTF1 YIPF2 ARID4A AAK1 LARS2 PCM1	2.93e-05	198	225	10	1061_DN
Drug	Diclofenac sodium [15307-79-6]; Up 200; 12.6uM; MCF7; HT_HG-U133A	AMACR PHC3 PAPOLA ZEB1 TBC1D30 AAK1 CD6 IRAK3 DUSP10 PCM1	2.93e-05	198	225	10	7215_UP
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; PC3; HT_HG-U133A	KDM6B YIPF2 SYNJ1 BUB1 AKAP5 SH3D21 CD6 MED25 HCFC1 PCM1	2.93e-05	198	225	10	6616_UP
Drug	Trapidil [15421-84-8]; Up 200; 19.4uM; MCF7; HT_HG-U133A	KATNB1 MECOM PHC3 CLBA1 NRF1 AAK1 SIPA1 CEP164 CD6 BRD4	3.05e-05	199	225	10	6515_UP
Drug	Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	TSC22D2 LILRB1 PHC3 ADAMTSL4 SZT2 POM121L2 CEP164 ARHGDIG CD6 TNK2	3.05e-05	199	225	10	3169_UP
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	KATNB1 C2CD2L SBF1 MAGED2 MICAL3 CENPT SOX13 CD6 HCFC1 PCM1	3.05e-05	199	225	10	7439_UP
Drug	Foliosidine [2520-38-9]; Up 200; 13uM; PC3; HT_HG-U133A	ZNF280B TSC22D2 BUB1 NKTR PLG ADAMTSL4 CSN2 GGA1 PCM1 RBM34	3.05e-05	199	225	10	4295_UP
Drug	Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; HL60; HT_HG-U133A	TSC22D2 CUL7 KDM6B AAK1 SIPA1 SEC31B SMARCA4 GGA1 PBXIP1 HCFC1	3.19e-05	200	225	10	1278_DN
Drug	Coenzyme A	KAT2B ACOT8	9.72e-05	2	225	2	ctd:D003065
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	SECISBP2L KATNB1 MED14 NKTR DSCAM SZT2 CEP290 ATG2B PBXIP1	1.02e-04	186	225	9	1664_UP
Drug	alpha-hydroxyalprazolam	PPIG ZEB1 CREB3L1	1.09e-04	10	225	3	CID000162244
Drug	5279552; Up 200; 22uM; MCF7; HT_HG-U133A_EA	BCORL1 TSC22D2 PAPOLA CLBA1 ZFAND3 DSCAM SOX13 PCM1 AHNAK2	1.30e-04	192	225	9	960_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	BCORL1 PPP1R13L C2CD2L BAHCC1 LARS2 SOX13 MED25 SMARCA4 HCFC1	1.35e-04	193	225	9	3262_UP
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A	CUL7 C2CD2L MICAL3 SZT2 SH3D21 BICDL1 MED25 SMARCA4 INPP5J	1.35e-04	193	225	9	4322_UP
Drug	Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	CUL7 KMT2A NKTR SZT2 TEX14 SH3D21 BICDL1 GGA1 RBM34	1.35e-04	193	225	9	3850_UP
Drug	pseudohypericin	AXIN2 PPIG HTR6 CAVIN3	1.36e-04	27	225	4	CID005281751
Drug	Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A	MAZ SYNJ1 TBC1D30 SZT2 SOX13 RLN2 CD5 PBXIP1 HCFC1	1.40e-04	194	225	9	4310_UP
Drug	Leflunomide [75706-12-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A	CYLD CUL7 PHC3 ZEB1 POM121L2 SIPA1 SH3D21 CD5 TNK2	1.40e-04	194	225	9	6102_UP
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A	PPRC1 KMT2A ZFAND3 CENPT NR1H3 RFWD3 MED25 ACIN1 PBXIP1	1.40e-04	194	225	9	4524_DN
Drug	ionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA	IMPG1 SYNPO2L MED9 KMT2D MED25 IRAK3 HERPUD1 NEK11 INPP5J	1.46e-04	195	225	9	871_UP
Drug	radicicol; Up 200; 0.1uM; PC3; HG-U133A	SLK MED14 PAPOLA DLG1 CREB3L1 BICDL1 CD5 TNK2 PBXIP1	1.46e-04	195	225	9	449_UP
Drug	Prednisone [53-03-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	MAZ KDM6B RTF1 TMEM156 DLG1 TCF4 TEX14 RFWD3 PCM1	1.46e-04	195	225	9	4577_UP
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; HL60; HT_HG-U133A	KPNA6 LILRB1 PHC3 TCF4 TBC1D30 CEP290 LARP1 IRAK3 GGA1	1.46e-04	195	225	9	1296_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	CYLD TSC22D2 LILRB1 NKTR SZT2 AAK1 POM121L2 PRX CD6	1.46e-04	195	225	9	5576_UP
Drug	Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A	KATNB1 DGKG MAGED2 KMT2A AFDN TBC1D30 AAK1 SIPA1 PCM1	1.46e-04	195	225	9	3135_DN
Drug	Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A	TSC22D2 YIPF2 PAPOLA CEP290 LMTK2 TNS2 CD6 ZFHX4 PBXIP1	1.52e-04	196	225	9	4974_UP
Drug	Felbinac [5728-52-9]; Down 200; 18.8uM; MCF7; HT_HG-U133A	TSC22D2 KDM6B SBF1 SASH1 CEP164 MADD PBXIP1 HCFC1 PINK1	1.52e-04	196	225	9	5700_DN
Drug	Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; HL60; HT_HG-U133A	MAGED2 KMT2A BAHCC1 TNS2 SH3D21 TRIM33 TNK2 PCM1 RBM34	1.52e-04	196	225	9	1849_UP
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; HL60; HT_HG-U133A	CUL7 KDM6B BUB1 DLG1 TCF4 BRD4 GGA1 PCM1 PINK1	1.52e-04	196	225	9	1315_DN
Drug	Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; HL60; HG-U133A	SECISBP2L MED14 DHX9 PPIG BUB1 TCF4 AAK1 ZMYM4 PCM1	1.52e-04	196	225	9	1423_DN
Drug	Reserpinic acid hydrochloride; Down 200; 9.2uM; MCF7; HT_HG-U133A	KATNB1 YIPF2 SBF1 BAHCC1 SASH1 TBC1D30 MED9 RLN1 PINK1	1.52e-04	196	225	9	4948_DN
Drug	Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; HL60; HT_HG-U133A	ZNF236 YIPF2 BAHCC1 CENPT SIPA1 MADD TNK2 PBXIP1 HCFC1	1.52e-04	196	225	9	1344_UP
Drug	Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A	BCORL1 C2CD2L SBF1 MED9 LMTK2 SIPA1 ARHGDIG BRD4 PCM1	1.57e-04	197	225	9	7411_UP
Drug	PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A	CYLD AMACR DDN KDM6B TBC1D30 MED9 MED25 PBXIP1 RAI2	1.57e-04	197	225	9	6545_DN
Drug	Lidoflazine [3416-26-0]; Up 200; 8.2uM; MCF7; HT_HG-U133A	AMACR PHC3 PLG AKAP5 SH3D21 CEP164 ARHGDIG CD6 DUSP10	1.57e-04	197	225	9	3201_UP
Drug	Finasteride [98319-26-7]; Up 200; 10.8uM; PC3; HT_HG-U133A	ZNF280B AFDN CLBA1 ZEB1 POM121L2 CREB3L1 MED25 PBXIP1 HCFC1	1.57e-04	197	225	9	3744_UP
Drug	Florfenicol [73231-34-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	SECISBP2L MAZ TSC22D2 CUL7 BAHCC1 RLN1 ARHGDIG TNK2 PCM1	1.57e-04	197	225	9	5300_UP
Drug	PHA-00851261E [724719-49-7]; Up 200; 10uM; MCF7; HT_HG-U133A	SYNPO2L DGKG MECOM TCF4 AKAP5 SZT2 POM121L2 GGA1 AHNAK2	1.57e-04	197	225	9	3965_UP
Drug	Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; HL60; HT_HG-U133A	JADE3 SNX19 MYO5C TMEM156 PAPOLA MICAL3 CENPT AAK1 RFWD3	1.57e-04	197	225	9	2389_DN
Drug	Gelsemine [509-15-9]; Down 200; 12.4uM; MCF7; HT_HG-U133A	CYLD PHC3 SBF1 BUB1 CLBA1 ZEB1 AAK1 TEX14 PBXIP1	1.57e-04	197	225	9	4177_DN
Drug	Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A	YIPF2 SBF1 AFDN NKTR BAHCC1 TBC1D30 MED25 PBXIP1 RAI2	1.57e-04	197	225	9	6611_DN
Drug	Naproxen [22204-53-1]; Down 200; 17.4uM; PC3; HT_HG-U133A	CYLD DDN TCF4 CENPT DSCAM AAK1 BRD4 TNK2 PCM1	1.57e-04	197	225	9	6358_DN
Drug	Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; PC3; HT_HG-U133A	AMACR DDN GC YIPF2 BUB1 AFDN CLBA1 RLN1 NEK11	1.57e-04	197	225	9	5741_UP
Drug	Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A	CYLD DDN CUL7 PLG SH3D21 PRX ARHGDIG BICDL1 HCFC1	1.64e-04	198	225	9	2288_UP
Drug	Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A	KDM6B ZNF236 PHC3 SBF1 BAHCC1 NRF1 CREB3L1 ACIN1 DUSP10	1.64e-04	198	225	9	3681_DN
Drug	Metolazone [17560-51-9]; Down 200; 11uM; PC3; HT_HG-U133A	KPNA6 CUL7 SNX19 DHX9 HOXA2 SBF1 NR1H3 SIPA1 SOX13	1.64e-04	198	225	9	6292_DN
Drug	estradiol, USP; Up 200; 0.01uM; PC3; HT_HG-U133A	ZNF362 SZT2 CREB3L1 ARHGDIG DNAI2 INPP5J PCM1 RBM34 RAI2	1.64e-04	198	225	9	1241_UP
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	C2CD2L SBF1 MAMLD1 AAK1 TNS2 SOX13 MADD TNK2 HCFC1	1.64e-04	198	225	9	7177_DN
Drug	Fenofibrate [49562-28-9]; Down 200; 11uM; HL60; HT_HG-U133A	BCORL1 DDN KDM6B PHC3 YIPF2 TCF4 AAK1 MED25 HCFC1	1.64e-04	198	225	9	2401_DN
Drug	Bisoprolol fumarate; Down 200; 9uM; HL60; HT_HG-U133A	MAZ BCORL1 KPNA6 KDM6B KMT2A LARP1 SEC31B SMARCA4 IRAK3	1.64e-04	198	225	9	1287_DN
Drug	(S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A	MAZ MED14 TSC22D2 ZFAND3 SASH1 SOX13 HCFC1 PCM1 PINK1	1.64e-04	198	225	9	5325_DN
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	CUL7 BAHCC1 RALGDS CENPT SOX13 BRD4 GGA1 HCFC1 INPP5J	1.64e-04	198	225	9	7035_UP
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; MCF7; HT_HG-U133A	ZNF362 CUL7 CLBA1 DSCAM SZT2 CEP164 BRD4 DUSP10 RBM34	1.70e-04	199	225	9	1470_UP
Drug	Azathioprine [446-86-6]; Down 200; 14.4uM; PC3; HG-U133A	CYLD SNX19 C2CD2L RTF1 SERTAD3 TCF4 ZEB1 SASH1 PCM1	1.70e-04	199	225	9	1945_DN
Drug	Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; PC3; HG-U133A	CYLD PPP1R13L SNX19 YIPF2 RALGDS TCF4 MAMLD1 ACIN1 DUSP10	1.76e-04	200	225	9	1952_DN
Drug	Thonzonium bromide [553-08-2]; Down 200; 6.8uM; HL60; HT_HG-U133A	DGKG ZNF280B SBF1 ZFAND3 CENPT NRF1 CEP290 TNK2 PBXIP1	1.76e-04	200	225	9	3080_DN
Disease	Sezary Syndrome	KMT2C ZEB1 KMT2D SMARCA4	4.69e-05	27	221	4	C0036920
Disease	Kleefstra syndrome 2 (implicated_via_orthology)	KMT2C KMT2D	5.58e-05	2	221	2	DOID:0080598 (implicated_via_orthology)
Disease	triglycerides to total lipids in medium VLDL percentage	ANKRD31 PLG SMARCA4 HERPUD1 TP53BP1	1.11e-04	63	221	5	EFO_0022335
Disease	congenital heart disease (implicated_via_orthology)	AXIN2 KMT2C KMT2A KMT2D HCFC1	1.71e-04	69	221	5	DOID:1682 (implicated_via_orthology)
Disease	Down syndrome (implicated_via_orthology)	DSCAML1 SYNJ1 DSCAM	1.76e-04	15	221	3	DOID:14250 (implicated_via_orthology)
Disease	free cholesterol to total lipids in very small VLDL percentage	PLG SMARCA4 HERPUD1 TP53BP1	3.01e-04	43	221	4	EFO_0022290
Disease	Myeloid Leukemia	MECOM KMT2A ATG2B	3.11e-04	18	221	3	C0023470
Disease	Leukemia, Monocytic, Chronic	MECOM KMT2A ATG2B	3.11e-04	18	221	3	C0023466
Disease	cholesteryl esters to total lipids in small VLDL percentage	ANKRD31 SEC16A SMARCA4 HERPUD1	4.98e-04	49	221	4	EFO_0022256
Disease	Thymoma	CYLD PBRM1	5.50e-04	5	221	2	C0040100
Disease	Fuchs Endothelial Dystrophy	TCF4 ZEB1	5.50e-04	5	221	2	C0016781
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	ANKRD31 PLG MADD SMARCA4 HERPUD1 TP53BP1	7.79e-04	144	221	6	EFO_0004611, EFO_0020943
Disease	metabolic syndrome	KMT2A PLG NR1H3 SIPA1 RBM6 SMARCA4 HERPUD1	8.11e-04	200	221	7	EFO_0000195
Disease	laryngeal carcinoma (is_marker_for)	KMT2C UBR5	8.21e-04	6	221	2	DOID:2600 (is_marker_for)
Disease	early-onset Parkinson's disease (implicated_via_orthology)	SYNJ1 PINK1	8.21e-04	6	221	2	DOID:0060894 (implicated_via_orthology)
Disease	Hereditary, Type VII, Motor and Sensory Neuropathy	AMACR PRX	8.21e-04	6	221	2	C0019816
Disease	Hereditary Motor and Sensory Neuropathies	AMACR PRX	8.21e-04	6	221	2	C0027888
Disease	Fuchs' endothelial dystrophy (is_implicated_in)	TCF4 ZEB1	8.21e-04	6	221	2	DOID:11555 (is_implicated_in)
Disease	oral mucosa leukoplakia (is_marker_for)	AXIN2 SNAI1	8.21e-04	6	221	2	DOID:9655 (is_marker_for)
Disease	triglycerides to total lipids in medium HDL percentage	PLG NR1H3 HERPUD1 TP53BP1	8.29e-04	56	221	4	EFO_0022333
Disease	free cholesterol to total lipids in medium VLDL percentage	ANKRD31 SMARCA4 HERPUD1 TP53BP1	8.86e-04	57	221	4	EFO_0022284
Disease	Antiglaucoma preparations and miotics use measurement	MECOM KMT2A FNBP4	9.49e-04	26	221	3	EFO_0009944
Disease	cholesterol to total lipids in small LDL percentage	ANKRD31 SMARCA4 HERPUD1	1.06e-03	27	221	3	EFO_0022241
Disease	triglycerides to total lipids in large HDL percentage	PLG MADD HERPUD1 TP53BP1	1.08e-03	60	221	4	EFO_0022330
Disease	Dejerine-Sottas Disease (disorder)	AMACR PRX	1.14e-03	7	221	2	C0011195
Disease	Thymic Carcinoma	CYLD PBRM1	1.14e-03	7	221	2	C0205969
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	PLG SMARCA4 HERPUD1 TP53BP1	1.14e-03	61	221	4	EFO_0008317, EFO_0008596, EFO_0020946
Disease	lung small cell carcinoma (is_implicated_in)	AXIN2 KMT2D PBRM1	1.18e-03	28	221	3	DOID:5409 (is_implicated_in)
Disease	prostate carcinoma	SLK MECOM ZNF280B ZNF236 PHC3 PCDH15 ADAMTSL4 KPNA2 CCHCR1 TCF4 LMTK2 PPP1R13B PKD1L3 SOX13 TAB3 PBXIP1	1.18e-03	891	221	16	EFO_0001663
Disease	Parkinson's disease (implicated_via_orthology)	PPRC1 AXIN2 SYNJ1 AAK1 EIF4G1 PINK1	1.22e-03	157	221	6	DOID:14330 (implicated_via_orthology)
Disease	cholesterol to total lipids in medium VLDL percentage	ANKRD31 PLG SMARCA4 TP53BP1	1.29e-03	63	221	4	EFO_0022239
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	ANKRD31 SEC16A PLG SIPA1 SMARCA4 HERPUD1 TP53BP1	1.48e-03	222	221	7	EFO_0008317, EFO_0020943
Disease	Cornelia De Lange Syndrome	KMT2A BRD4	1.52e-03	8	221	2	C0270972
Disease	Lymphoid leukemia	MECOM KMT2A	1.52e-03	8	221	2	C0023448
Disease	breast carcinoma (is_marker_for)	AMACR KDM6B AFDN KMT2D	1.53e-03	66	221	4	DOID:3459 (is_marker_for)
Disease	total lipids in small VLDL	ANKRD31 GC HERPUD1 TP53BP1	1.62e-03	67	221	4	EFO_0022148
Disease	free cholesterol in large VLDL measurement	ANKRD31 PLG HERPUD1 TP53BP1	1.71e-03	68	221	4	EFO_0022265
Disease	fatty acid measurement	ANKRD31 DSCAML1 JMY KMT2A TMEM223 PLG CD5 SMARCA4 HERPUD1 TP53BP1	1.77e-03	436	221	10	EFO_0005110
Disease	insomnia measurement	RREB1 UBR5 PCDH15 KMT2A TCF4 FBXL17 PBRM1 RBM6 DGKI PRDM15	1.98e-03	443	221	10	EFO_0007876
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	PLG SMARCA4 HERPUD1	2.09e-03	34	221	3	EFO_0008317, EFO_0008596, EFO_0020944
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	ANKRD31 SEC16A PLG SIPA1 SMARCA4 HERPUD1 TP53BP1	2.25e-03	239	221	7	EFO_0008317, EFO_0020945
Disease	free cholesterol to total lipids in small VLDL percentage	ANKRD31 PLG SMARCA4 TP53BP1	2.46e-03	75	221	4	EFO_0022287
Disease	free cholesterol to total lipids in large VLDL percentage	SEC16A SMARCA4 HERPUD1	2.67e-03	37	221	3	EFO_0022281
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	PLG SEC31B HERPUD1 TP53BP1	2.83e-03	78	221	4	EFO_0022187
Disease	Schizophrenia	AMACR GC LILRB1 KMT2A DLG1 PLG TAPBP TCF4 HTR6 LCN2 LARS2 PBRM1 CALY PCM1 PINK1	2.84e-03	883	221	15	C0036341
Disease	gastric adenocarcinoma (is_implicated_in)	UBR5 KMT2D	2.94e-03	11	221	2	DOID:3717 (is_implicated_in)
Disease	invasive ductal carcinoma (is_implicated_in)	UBR5 DLG1	2.94e-03	11	221	2	DOID:3008 (is_implicated_in)
Disease	cholesterol in large HDL measurement	PLG MADD HERPUD1 TP53BP1	3.11e-03	80	221	4	EFO_0021900
Disease	Graves' disease (is_implicated_in)	GC C4A C4B	3.11e-03	39	221	3	DOID:12361 (is_implicated_in)
Disease	triglycerides to total lipids in large VLDL percentage	ANKRD31 SMARCA4 HERPUD1	3.11e-03	39	221	3	EFO_0022332
Disease	lipoprotein-associated phospholipase A(2) measurement	PLG HERPUD1 TP53BP1	3.34e-03	40	221	3	EFO_0004746
Disease	Renal dysplasia and retinal aplasia (disorder)	CEP290 CEP164	3.51e-03	12	221	2	C0403553
Disease	acute myeloid leukemia (implicated_via_orthology)	KMT2A ARID4A	3.51e-03	12	221	2	DOID:9119 (implicated_via_orthology)
Disease	Myeloproliferative disease	MECOM ATG2B	3.51e-03	12	221	2	C0027022
Disease	rheumatic heart disease (biomarker_via_orthology)	ZEB1 SNAI1	3.51e-03	12	221	2	DOID:0050827 (biomarker_via_orthology)
Disease	very low density lipoprotein cholesterol measurement	ANKRD31 GC DSCAML1 PLG SMARCA4 HERPUD1 TP53BP1	3.59e-03	260	221	7	EFO_0008317
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	ANKRD31 SEC16A PLG SIPA1 SMARCA4 HERPUD1 TP53BP1	3.90e-03	264	221	7	EFO_0008317, EFO_0020944
Disease	Papillary thyroid carcinoma	ZEB1 TRIM33 SNAI1 PCM1	4.03e-03	86	221	4	C0238463
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	TSC22D2 PLG NR1H3 SMARCA4 HERPUD1 TP53BP1	4.08e-03	200	221	6	EFO_0004611, EFO_0020945
Disease	Memory Loss	AKAP5 HTR6 CALY	4.10e-03	43	221	3	C0751295
Disease	Age-Related Memory Disorders	AKAP5 HTR6 CALY	4.10e-03	43	221	3	C0751292
Disease	Memory Disorder, Spatial	AKAP5 HTR6 CALY	4.10e-03	43	221	3	C0751294
Disease	Memory Disorder, Semantic	AKAP5 HTR6 CALY	4.10e-03	43	221	3	C0751293
Disease	Memory Disorders	AKAP5 HTR6 CALY	4.10e-03	43	221	3	C0025261
Disease	colon carcinoma (is_marker_for)	AXIN2 KMT2D	4.13e-03	13	221	2	DOID:1520 (is_marker_for)
Disease	Charcot-Marie-Tooth disease type 4	SBF1 PRX	4.13e-03	13	221	2	cv:C4082197
Disease	insulin measurement	CAAP1 TSC22D2 TCF4 SASH1 TBC1D30 DSCAM MADD	4.14e-03	267	221	7	EFO_0004467
Disease	pyruvate measurement	TCERG1L PPIG PCDH15 SASH1 TAB3 ZNF804B PRDM15	4.23e-03	268	221	7	EFO_0010117
Disease	smoking status measurement, chronic obstructive pulmonary disease	MECOM RREB1 MICAL3 POM121L2	4.37e-03	88	221	4	EFO_0000341, EFO_0006527
Disease	Memory impairment	AKAP5 HTR6 CALY	4.38e-03	44	221	3	C0233794
Disease	Multiple Sclerosis	MCAM GC CD6	4.67e-03	45	221	3	C0026769
Disease	cholesterol to total lipids in large VLDL percentage	ANKRD31 SMARCA4 HERPUD1	4.67e-03	45	221	3	EFO_0022236
Disease	Multiple Sclerosis, Acute Fulminating	MCAM GC CD6	4.67e-03	45	221	3	C0751324
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	TSC22D2 JMY PLG NR1H3 HERPUD1 TP53BP1	4.71e-03	206	221	6	EFO_0004612, EFO_0020947
Disease	schizophrenia, intelligence, self reported educational attainment	DDN SNX19 KMT2A TCF4 FBXL17 RBM6 DGKI DUSP10	4.75e-03	346	221	8	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	triacylglycerol 48:4 measurement	ZNF236 DSCAM	4.79e-03	14	221	2	EFO_0010407
Disease	sleep duration, low density lipoprotein cholesterol measurement	ANKRD31 PLG PKD1L3 SMARCA4	4.92e-03	91	221	4	EFO_0004611, EFO_0005271
Disease	triglyceride measurement, phospholipid measurement	TSC22D2 PLG NR1H3 HERPUD1 TP53BP1	4.95e-03	146	221	5	EFO_0004530, EFO_0004639
Disease	dimethylglycine measurement	JMY TMEM266 ZNF804B	4.96e-03	46	221	3	EFO_0010476
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	PLG SMARCA4 HERPUD1	4.96e-03	46	221	3	EFO_0008317, EFO_0008596, EFO_0020943
Disease	Neurodevelopmental Disorders	KMT2C KMT2A TCF4 DSCAM	5.32e-03	93	221	4	C1535926
Disease	age at menarche	UIMC1 DDN DSCAML1 TCF4 DSCAM AAK1 MADD ZFHX4 EIF4G1 RBM6 CFAP61	5.43e-03	594	221	11	EFO_0004703
Disease	level of Phosphatidylcholine (16:0_16:0) in blood serum	SMARCA4 HERPUD1	5.50e-03	15	221	2	OBA_2045067
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	ANKRD31 PLG SMARCA4 HERPUD1 TP53BP1	5.54e-03	150	221	5	EFO_0004611, EFO_0020947
Disease	smoking status measurement, carotid artery intima media thickness	TCERG1L FBXL17 TRIM33	5.59e-03	48	221	3	EFO_0006527, EFO_0007117
Disease	lung adenocarcinoma (is_implicated_in)	AXIN2 KMT2C UBR5	5.93e-03	49	221	3	DOID:3910 (is_implicated_in)
Disease	preeclampsia, hypertension, pregnancy-induced	MECOM TNS2	6.25e-03	16	221	2	EFO_0000668, MONDO_0024664
Disease	preeclampsia, parental genotype effect measurement	MECOM CCHCR1	6.25e-03	16	221	2	EFO_0000668, EFO_0005939
Disease	nervousness	FNBP4 MADD	6.25e-03	16	221	2	NCIT_C74532
Disease	amyloid-beta measurement, Alzheimer's disease biomarker measurement	RELCH CCDC181	6.25e-03	16	221	2	EFO_0005194, EFO_0006514
Disease	level of Phosphatidylcholine (18:0_18:2) in blood serum	ZNF362 HERPUD1	6.25e-03	16	221	2	OBA_2045090
Disease	triglycerides to total lipids in medium LDL percentage	SMARCA4 HERPUD1 TP53BP1	6.27e-03	50	221	3	EFO_0022334
Disease	phospholipids in very small VLDL measurement	SMARCA4 HERPUD1 TP53BP1	6.63e-03	51	221	3	EFO_0022300
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	PLG HERPUD1 TP53BP1	6.63e-03	51	221	3	EFO_0022302
Disease	cholesterol to total lipids in small VLDL percentage	ANKRD31 SMARCA4 HERPUD1	6.63e-03	51	221	3	EFO_0022242
Disease	free cholesterol to total lipids in small HDL percentage	MADD SMARCA4 HERPUD1	6.63e-03	51	221	3	EFO_0022285
Disease	chronotype measurement	DGKG PCDH15 TCF4 HTR6 MED9 FNBP4 FBXL17 TEX14 MADD TRIM33 KMT2D PRPF3 RBM6 CFAP61	6.95e-03	882	221	14	EFO_0008328
Disease	Colorectal Carcinoma	TCERG1L AMACR DSCAML1 AXIN2 KMT2C BUB1 RALGDS RELCH STAM EIF4G1 ACIN1 ZMYM4	6.97e-03	702	221	12	C0009402
Disease	proprotein convertase subtilisin/kexin type 7 measurement	DSCAML1 CEP164	7.05e-03	17	221	2	EFO_0008270
Disease	Benign neoplasm of stomach	AXIN2 UBR5	7.05e-03	17	221	2	C0153943

Protein segments in the cluster

Peptide	Gene	Start	Entry
IEVEPSPVQQDNPPI	nan	41	Q6ZRG5
PQVVPNNSSELPSPL	ZNF280B	131	Q86YH2
AEPPVPPQVSVEVAL	ACIN1	946	Q9UKV3
QEVPIEIKPVNPSPL	ACOT8	181	O14734
PAAIPATPVAVSQPI	AFDN	1346	P55196
LQQVLPLPLPPDSDS	HTR6	366	P50406
PSVFPLPQDAPTQLV	BAHCC1	861	Q9P281
PTLEPVTEPPANLDR	CFAP61	1016	Q8NHU2
EQSPELPVDPLAAPS	CREB3L1	131	Q96BA8
PVPPEELQPEQVAEL	EGFL8	241	Q99944
NSLVSIPPALPPVVQ	ARID4A	986	P29374
PQLQPEILRVEPPLA	ADAMTSL4	616	Q6UY14
REAPPVVPPLANAIS	BUB1	356	O43683
QPEAQPALEPTLEPE	CAVIN3	221	Q969G5
PVLPVLEEAPQTPVA	CCDC88B	496	A6NC98
LADEPAAIVPPPSVQ	CXorf49;	101	A8MYA2
PDAPLQPVTPLQLFE	C4B	1431	P0C0L5
LEPPVPQRLPSQTES	AAK1	836	Q2M2I8
AQPPQVLLEDEEPPA	BRD4	906	O60885
QDVSPRPAPLLLNTP	AMACR	321	Q9UHK6
IPVLPVPAENTVILP	DLG1	176	Q12959
TIPQANPPPVLVNTD	DLG1	191	Q12959
NPPPVLVNTDSLETP	DLG1	196	Q12959
SVPVSAPPLALIQAP	BCORL1	306	Q5H9F3
TLQVVPPSDPDPLLA	AJM1	411	C9J069
PEPTAPPRLQLVAQS	CD5	151	P06127
PPLTPPNTLAQLEEA	AXIN2	686	Q9Y2T1
PEPTNPFQPIASVII	ARL13B	251	Q3SXY8
AVLQALEVLPVAPPP	ATAD2	951	Q6PL18
LAVPPPEDVQPSAQQ	CAAP1	321	Q9H8G2
SVLLNSLPPQAAPVP	CD177	306	Q8N6Q3
VPRTPPAEELAEPQA	NPPC	31	P23582
TPVPQQPSPEEDQVV	DNAI2	571	Q9GZS0
LPAPEVNLRDAPTQP	DDN	551	O94850
PPPSQDPELLSVIRQ	BICDL1	91	Q6ZP65
ALPQLETPPNPSALL	CAMSAP3	91	Q9P1Y5
LPSPEPEELICPQTT	PPP1R13B	796	Q96KQ4
IDPLSPPETSQNLNP	ATG2B	521	Q96BY7
EVRPSPSTPLEVPLN	ADAMTS2	1131	O95450
LREAQSPEEPTPLPV	TNK2	876	Q07912
EGQILEQPLDPSLIP	CCDC80	206	Q76M96
PSVQESPLSPPALAQ	ATP1A1-AS1	46	Q5TC04
QSPPCPRLSQELPEV	NBPF4	411	Q96M43
PQLLDLRIPSQPQEP	RAI2	166	Q9Y5P3
LRIPSQPQEPTLPFE	RAI2	171	Q9Y5P3
SSLEPQIQPVYVPVP	RBM34	61	P42696
LLPDTPVQFIPPNTL	RBM44	976	Q6ZP01
TLSPQPLLTPQDPTA	PCP2	106	Q8IVA1
TPPLLQPAPQLSVDL	RFWD3	66	Q6PCD5
DAPQTPRPVAEIVPS	RLN2	61	P04090
PVPEVVQELPLTSPV	OCLN	346	Q16625
EAPRPIPSIPQDLES	GOLGA8S	431	H3BPF8
AQEIPVVSAPAPAPI	HERPUD1	201	Q15011
TPLLAETPAPEQPAE	PALM3	606	A6NDB9
TELVPPDPQQPQASA	KIAA1549	1776	Q9HCM3
ASSPPQILPQLSPEQ	NR1H3	196	Q13133
PPVTPATSQDQPLDL	MECOM	761	Q03112
LPIQVQAPPPEDSDS	CD6	466	P30203
EDAPILPEPNSVPQQ	ANKRD31	1781	Q8N7Z5
SVPENSPPNTPVIRL	PCDH19	246	Q8TAB3
SNLPPTLETPQPAEN	RELCH	341	Q9P260
VVQPPPPTQSEVDQL	HCFC1	1571	P51610
DTLTPEPPVDPNQEV	LARP1	721	Q6PKG0
EPSPPIDEVINTPRV	KPNA6	111	O60684
VIEPPSLPQLQTPLA	PBRM1	1336	Q86U86
LREAEPNASVVPPPL	MICAL3	1476	Q7RTP6
PPAPSRIPIQDSLSQ	KMT2C	1856	Q8NEZ4
APTNAEVLPILPEPE	MADD	406	Q8WXG6
QEPEAPPPRDVALLQ	MAGED2	266	Q9UNF1
PPTISLPLLNNNLEP	JMY	781	Q8N9B5
PSPTPPRADLQQIIV	KAT2B	116	Q92831
PPPLVEITPRDQLLN	LMOD3	526	Q0VAK6
ATLSPELPPVEPQLE	IMPG1	406	Q17R60
VASVQQVPPRLPPEA	MAPK15	481	Q8TD08
QLPVQSATSPDLNPP	TCF4	476	P15884
LLSPPIIPSDQNIPV	HECTD2	531	Q5U5R9
AQNPQDPPLVPLTLA	KDM6B	591	O15054
PNLEVLPRPPVVAST	KATNB1	431	Q9BVA0
LLPQPIPTTPDIENA	DUSP10	306	Q9Y6W6
EVSIDLLAEPSNPPP	ISM2	221	Q6H9L7
DSTQQPNPLPLRLPE	PCM1	1896	Q15154
LPALPESVPPDVRQL	PINK1	471	Q9BXM7
IEDTPLVPQAPPNTD	PCDHGA9	801	Q9Y5G4
EPPSQSPNTPLQRLV	CUL7	611	Q14999
QGETLLQELPIPPDT	FAM205A	936	Q6ZU69
PAPQEVNSELPPLTI	NRF1	176	Q16656
LLQDLSEVSAPPLPP	HEXD	461	Q8WVB3
DEPTLENLPESQPIP	NEK11	431	Q8NG66
PTPQAPAAEPLQVDL	MAZ	71	P56270
VQEQPLPEPVLPEQS	LMTK2	1131	Q8IWU2
LPEPVLPEQSPAAQD	LMTK2	1136	Q8IWU2
PALLEPLQPPTDVSQ	MED25	201	Q71SY5
PPQQPVPTELSLASI	GGA1	486	Q9UJY5
ESQELQAPVPLLPPT	LRRC10	261	Q5BKY1
PSPLFLENVPSIPVE	IRAK3	466	Q9Y616
LDQPEQTTIPIPQLP	PRDM10	451	Q9NQV6
NIEITPTPAQPAPAL	PRSS38	291	A1L453
AEALVQLPFQTLPPP	PHC3	551	Q8NDX5
PRDITTVIPQIPPDN	DSG1	606	Q02413
PPQSTEPVCLPQETE	DSG1	776	Q02413
QAEDVLPPTSDQPLP	MED9	11	Q9NWA0
CPDVLPQTPPLEEIS	PIPSL	456	A2A3N6
EPPVIQPQPSELHVI	HMCN1	3986	Q96RW7
PPQEPVSIIVPIIYD	MED14	1376	O60244
IPPLPEPLQSQTHSV	SBF1	321	O95248
AQPQSTVRPEEIPPI	PPIG	266	Q13427
LPPAPLISEIPDTQE	HFM1	36	A2PYH4
NPAPPIDAVEQILPT	KPNA2	241	P52292
LSDIPALPANPIPVI	PAPOLA	721	P51003
DLIPAPPLSKVPLQQ	LCN2	26	P80188
LQPELPTQEDPTPEI	PRRT2	156	Q7Z6L0
TPEELNPIIVTPPIQ	PCDH15	291	Q96QU1
NDIISVPGIQPLDPI	CCDC181	81	Q5TID7
EDQVAATPLEPPVPR	DGKG	136	P49619
QPLLPSPSEQEEELP	FRMD3	381	A2A2Y4
SPLDISQLQPPLPDQ	CALY	31	Q9NYX4
LPPTQLEVNLEEIPG	C2CD2L	186	O14523
PPAVDPSLPNVQVTR	ARHGDIG	81	Q99819
SIPDPSLPLPNQLEI	CEP290	1441	O15078
PPNILPTPSLELEEA	DEFB129	166	Q9H1M3
DELQLSPQPPVGVLP	DGKI	446	O75912
QLTVQEPPDPPELEI	DSCAML1	881	Q8TD84
PTPDTQLDTEQPPRL	DMBX1	156	Q8NFW5
PETPDINQLPPSILL	FBXL17	316	Q9UF56
VPSAVPRPTLEPAEQ	GGT6	286	Q6P531
AVVAEPPVQLSPSPL	BATF2	161	Q8N1L9
QPSLTAQTAPPQPLE	BATF2	196	Q8N1L9
ELQLPELEPPTTLAP	CENPT	131	Q96BT3
ILPLAQPAVVLPVPQ	CSN2	81	P05814
VLSDVPPLPAIPDQQ	AKAP5	261	P24588
PPLPAIPDQQIVEEA	AKAP5	266	P24588
QLRQESCPLPPPVTD	CCHCR1	486	Q8TD31
PVPIAPTAQPEELLN	EIF4G1	391	Q04637
EELLPPESTPIPANL	EIF4G1	481	Q04637
AELQVPPLTINPSPA	MAMLD1	106	Q13495
QDPAPSQTLELEPAP	RALGDS	341	Q12967
SLLLEQSPVPEPLPQ	CDCA2	431	Q69YH5
DISILQPSNVPPPQI	IL22RA1	331	Q8N6P7
IGVQPPPDPQLLVSE	KMT2A	3186	Q03164
SPQPLAVAAPQLPVL	E4F1	401	Q66K89
IPPQAQELEIPLTPQ	FAM186A	1556	A6NE01
PLQPPPVNSLTTENR	CYLD	401	Q9NQC7
ALSQPPLVAVPLPQA	ERVFC1	256	P60507
PEETGPVLPQEINPQ	SAMD15	376	Q9P1V8
TRLQPALPPEAQSVP	PPP1R13L	491	Q8WUF5
LVEPLPAEPVLINPV	PPRC1	621	Q5VV67
AVDPAVVPISDNLPP	PPRC1	641	Q5VV67
VVPISDNLPPVDAVP	PPRC1	646	Q5VV67
VDPVPNDLTPVDPVL	PPRC1	671	Q5VV67
QVPASPDTVPQPSLR	JADE3	81	Q92613
PDAPLQPVTPLQLFE	C4A	1431	P0C0L4
LPTRPAPPTVEQILE	C19orf25	11	Q9UFG5
QELNLEILPPPEDPS	DHX9	291	Q08211
PAQLNPPVDNDTPVT	PRPF3	421	O43395
IQIIADPPLPPASFT	MTERF3	131	Q96E29
TLIPPPFEQTIPSLN	HOXA2	46	O43364
PEEPNIQVNPLGIPV	MCAM	136	P43121
GIIQLTVQEPPDPPE	DSCAM	876	O60469
EPPDITQIYPVPANI	FER1L6	971	Q2WGJ9
IPPKSQPVSLPEELN	RTF1	346	Q92541
QPTAEPLAPTVLAPR	SYNPO2L	896	Q9H987
PVQPQDSESPPAQLV	SZT2	3396	Q5T011
PPVDPNILDYIQPST	RBM6	286	P78332
NLPSLPDIPPIQLED	TRIM33	676	Q9UPN9
QPTEPQPVLIPSINI	SLK	701	Q9H2G2
PDALLQPPIRSPENT	TEX14	971	Q8IWB6
PPPDSQETLALPSLV	SH3D21	546	A4FU49
LPQPPLSLIAENKPV	TSC22D2	601	O75157
RSAAPEPIQPISVIP	TAB3	476	Q8N5C8
SSLPPPAQRLQEPLV	SYNJ1	1251	O43426
PVPLEDLPVTLPNIA	LARS2	471	Q15031
LQSNVPVLQPPLPLE	FNBP4	696	Q8N3X1
QPGPIVAPEETLTLQ	LILRB1	231	Q8NHL6
VAENIPVIPLSDSPP	NKTR	601	P30414
QSPPCPRLSQELPEV	NBPF6	411	Q5VWK0
DAPQTPRPVAEIVPS	RLN1	61	P04808
AVPQTDVLPPSQPQA	PRDM15	1471	P57071
PPATRVLETSPLQPQ	PNPLA5	401	Q7Z6Z6
IEPQETLPLFPPIQA	PKD1L3	971	Q7Z443
EEQPQAAQPPTLPVE	SMARCA4	671	P51532
PQDPRQPLADLTIPV	SPPL2C	136	Q8IUH8
PPALPNAAVSILEEP	SIPA1	186	Q96FS4
AVLQPSVEPTQPTPQ	SCAMP2	61	O15127
LPENSPINIVQTPIP	SECISBP2L	421	Q93073
LDVPAELQPEPLEPQ	PPP1R3G	261	B7ZBB8
PLQVPEQVAQAPLIP	SEC31B	361	Q9NQW1
QLAPTAPPELTPVVQ	PLG	361	P00747
SSPENLVSEIPPPQL	POM121L2	326	Q96KW2
VTPLGLQNEVPPQPD	SERTAD3	116	Q9UJW9
EQPVDLNLPLEAPPI	AHNAK2	5446	Q8IVF2
PPSAEQIDFVPVQPL	ANKHD1	916	Q8IWZ3
ILDSLNPQSPPPLLA	CEP164	1281	Q9UPV0
QSLELLEGPTEPQPP	CLBA1	96	Q96F83
AVTCPPPQLAVNLEP	CLEC17A	126	Q6ZS10
PQTDISISPALPELP	CLEC19A	21	Q6UXS0
LPLDQVQEVLPPIPE	TMEM156	281	Q8N614
PSPVLSPTQEQALAP	INPP5J	206	Q15735
PEEQGPEPLPISTQE	SINHCAF	206	Q9NP50
TPPPQILLPLEERVT	TCERG1L	441	Q5VWI1
PLEEPTTEPPVNLTY	ZG16B	186	Q96DA0
LAAIPPPEILNPTAS	SNAI1	41	O95863
VTPDSQLALPIQPIP	SOX13	241	Q9UN79
PSAPPQVQLPVSLDL	ZFHX4	2016	Q86UP3
AVSRPPVPVQPLDAE	TMEM223	66	A0PJW6
PPLIQQPITFSPDEI	ZNF804B	1141	A4D1E1
EQLQAPVPPDSVPSL	PBXIP1	251	Q96AQ6
SSPPTESLQNPPVLI	SEC16A	816	O15027
PPVTEELPPLASIAQ	RREB1	1056	Q92766
QVPQVELPALPSLPT	PRX	291	Q9BXM0
SSLLRPQPEPQQEPV	TAPBP	136	O15533
VVENPLPETDSQPIP	HGS	371	O14964
PAAQLPELPDVELPT	GC	316	P02774
PEIPEPSLQEQLEVP	TROAP	531	Q12815
QPTPTIQEEPEPVSN	MYCBPAP	41	Q8TBZ2
QDVPTEVTEPPPQIV	SASH1	851	O94885
PPEQLSSLSQAVVPP	STAM	431	Q92783
QEEETIPAAPPAPRL	TBC1D30	31	Q9Y2I9
ELENPPLLPESTVSP	TP53BP1	416	Q12888
PVPQPLPSDDTRVEN	SART1	456	O43290
APEQPSVPTSLPLIA	SNX19	281	Q92543
PTEQEVPALTAPRAP	PRR33	231	A8MZF0
SEPVVNVIPPSANPI	ZEB1	786	P37275
LALEVPAQLPDPPTI	TXNDC11	431	Q6PKC3
PRQEAVPVVSLPAPS	ZC3H7A	211	Q8IWR0
QQPLLVPPAPAESSQ	ZNF362	66	Q5T0B9
TNIPVPDIPLQEPIL	ZNF236	611	Q9UL36
QPEVIPVPLPDTVLL	TRAPPC8	1011	Q9Y2L5
RPLVQATVPATPEQP	UQCRFS1P1	36	P0C7P4
AAQVPTVPVPPAAVL	WNK2	1036	Q9Y3S1
APPPQITSLPSNIAL	YIPF2	291	Q9BWQ6
PTLSPSQQPLPTELN	ZFAND3	76	Q9H8U3
GEPVLPRPPSLIQNE	UIMC1	321	Q96RL1
QELDQPPPYSTVVIP	TMEM139	106	Q8IV31
LSDNVPQTPEPPTQE	TNS2	1111	Q63HR2
EDTPSQPQIIVVPVP	ZMYM4	971	Q5VZL5
PPPLPSQQQVEEATV	TMEM266	426	Q2M3C6
PQPVIPASVIPEELI	UBR5	176	O95071
NDTRPDVEPPLPLQI	TTI1	846	O43156
VQEVETLPPGLTEPP	ZNF628	951	Q5EBL2
SPVLLDPEELAPVTP	KMT2D	1151	O14686
SVNPESLPPLRNPDI	MYO5C	51	Q9NQX4